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The following terms are used frequently in the text:
osteoblast- a cell arising from a fibroblast, which, as it matures, is associated with bone
production.
osteoclast- a large muhinuclear cell associated with the absorption and removal of bone.
trabecular (cancellus) bone- the lattice-like bone.
cortical bone- the compact bone.







Osteoporosis is a condition of skeletal fragility defined as a bone mass value
greater than 2.5 standard deviations below the young adult mean and characterized by
destruction of cancellous bone architecture. It is estimated that one in two women and
one in eight men over age 50 will suffer a fracture related to osteoporosis in their lifetime
(National Osteoporosis Foundation). Osteoporosis is a major public health concern due
to the condition's characteristic low bone mass, the deterioration of trabecular bone, and
the associated increased risk and incidence of fracture occurrence.
Bone formation begins before birth and continues until approximately the end of
the second decade of life (Matkovic 1996, Gilsanz 1988). During this time, mineral salts
are deposited onto a collagen matrix within bone by osteoblasts, and accumulation of bone
mass predominates producing peak bone mass. In young adulthood, bone accumulation is
replaced by bone remodeling in which osteoclastic cells resorb and osteoblastic cells
secrete bone minerals in response to physiological triggers. In older adulthood, bone
remodeling changes again and bone resorption exceeds bone formation due to decreased
osteoblastic activity (Heaney 1996). This results in a net loss of bone mass. Women
experience additional bone loss after menopause as osteoclastic activity increases in
response to the decreased production of the bone protective female honnone, estrogen.
Decreased bone mass leads to osteoporosis; therefore, greater bone mass at time
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ofonset of bone loss in later life should result in lower incidence or delayed onset of
osteoporosis and related fracture. Achievement ofpeak bone mass during growth and
maintenance ofbone mass in adulthood are major factors affecting bone mass and density
during later life. Several factors, including genetics, environmental factors, mechanical
loading, and nutrition, influence development and maintenance ofpeak: bone mass. Bone
mass has been found to be lower in women with osteoporotic mothers (Matkovic 1996.
JohnellI996). Environmental factors such as alcohol use. disease states, and drug
interactions have been shown to resuh in lower bone mass (Chestnut 1991, Heaney 1996).
Mechanical loading or weight bearing exercise can affect bone mass with increased
loading leading to increased mass (Chestnut 1991, Heaney 1996). Studies have
demonstrated a positive relationship between calcium intake and bone mass (Anderson et
al. 1996, Matkovic 1996. Angus et a1. 1988). WIth attainment ofpeak bone mass during
lxme growth and maintenance ofhomeostasis during adulthood, greater mass is present
when postmenopausal and/or age-related bone loss begins.
The investigation ofthe role ofnutrition in bone metabolism has been primarily
focused on calcium and vitamin D. It is commonly recognized that calcium is necessary
for bone health throughout life and that vitamin D is vital in calcium balance. Vitamin Cis
widely recognized as essential in collagen formation, the connective tissue foundation of
bone. Effects of other nutrients on bone metabolism have been less extensively studied.
Angus et a1. (1988) positively correlated dietary levels of the minerals magnesium, zinc,
and iron with forearm bone mineral content in premenopausal women. In a study of
connective tissue biosynthesis, O'Dell (1981) reported copper and iron are both required
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for post-translational maturation ofcollagen. To date, few studies have been performed
specifically investigating the effects oflevel ofdietary iron on bone metabolism ) tt
Dietary iron intakes vary greatly. Worldwide, iron intakes often fall below
recommendations, especially in children, females and the elderly (DeMaeyer and Adiels-
Tegman 1985). Conversely, increased iron intakes are more common with individual
supplement use and national food fortification policies (Olsson et al. 1997). Therefore, in
certain populations iron intake is inadequate, and in others iron intake could be excessive.
Dietary iron absorption also varies due to source, total meal content and
physiological state. Heme iron is better absorbed than non-heme iron. Ascorbic acid,
organic acids, and animal tissues consumed with non-home iron increases absorption while
phytates, polyphenols, calcium and psyllium fiber decrease absorption. Idiopathic or
secondary hemaclrromatosis, iron deficiency and periods ofrapid growth such as in
childhood and pregnancy increase iron absorption. Decreased hydrochloric acid
production associated with aging and secondary achlorhydria reduce iron absorption
(Lynch 1997).
As dietary iron intakes are often not optimal and iron plays a critical role in post-
translational collagen maturation, dietary iron concentration may affect bone metabolism
Because it has been demonstrated that both inadequate and excessive dietary iron intakes
affect bone metabolism (Rothman et al. 1971, Heppenstall and Brighton 1977, PaUares et
al. 1996, Campos et al. 1998, Lynch et al. 1970, de Vernejoul et a1. 1984, Storey and
Greger 1987, Diamond et al. 1989 and 1991, Conte et a1. 1989, Schnitzler et a1. 1994,
Duquenne et al. 1996), it can be hypothesized that both inadequate and excessive dietary
/
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iron intakes may affect connective tissue formation. Therefore~ inadequate bone
foundation formation and maintenance rates may result. If bone fonnation and peak mass
achievement are hindered during growth and mass is not maintained in early adulthood
due to suboptimal iron intake, less mass could be available to be lost in aging and estrogen
deficiency.
Females and elderly exhibit the highest incidence ofosteoporosis and associated
complications and often have dietary iron intakes inconsistent with current
recommendations. This study may propose dietary iron intake as one component of
osteoporosis prevention.
Postmenopausal osteoporosis is by far the most common cause ofage-related bone
loss (Heaney 1996). In human females, both natural and surgical menopause are associated
with an initial phase of rapid bone loss followed by a phase of continued but slower loss of
bone (Cohn et al. 1976). The bone loss is attributed to the imbalance between
osteoclastic bone resorption and osteoblastic bone fonnation secondary to ovarian
hormone deficiency. Similar patterns ofovarian hormone deficiency bone loss have been
observed in animals. Ovariectomized rats have exhibited increased bone resorption and net
bone loss (Wronski et al. 1985). Dick et aI. (1996) found in ovariectomized rats as in
postmenopausal women negative calcium balance and significant generalized bone loss.
Bagi et a1 (1996, 1997) found greater resorption rates than fonnation rates with
significantly lower femur bone mineral density in ovariectomized rats compared to sham-
operated rats. Because the rat hip and femoral neck were similar in structure and in
response to endocrine changes seen in humans, these investigators concluded that the rat
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model is suitable for studies ofbone metabolism and strength for application to
osteoporosis. In addition, Peng et aI. (1994) and Li et al (1997) support the use ofthe rat
femur over the tibia in osteoporosis research. The ovariectomized rat model has been
shown to be adequate as long as its limitations are considered (Rodgers et aL 1993, Peng et
aI. 1997).
Significance ofthe Problem
Osteoporosis-related fi'actures result in significant human and economic costs in the
United States with increased morbidity, mortality, and utilization ofheaJth care resources.
Miller (1978) demonstrated only 50% ofhip fracture patients regained pre-fi'acture
ambulatory ability within one year offracture. Schurch et aI. (1996) reported within one
year ofhip fracture 21.5% ofmen and 35.4% ofwomen followed were deceased.
Nationally, medical costs associated with osteoporotic fractures in 1995 have been
estimated at $38 million per day or $13.8 billion annually (National Osteoporosis
Foundation). These studies illustrate the current human and financial costs ofosteoporosis;
as the aging of the U.S. population continues into the 21st century, without intervention it
seems likely that both the incidence and costs ofosteoporosis related fractures will increase
in the coming years (Ray et al. 1997).
STIJDY PURPOSE AND OBJECTIVES
This study utilizes skeletally mature rats to clarify the association between dietary
iron, hormonal status, and bone metabolism. The cumulative effects of dietary iron on
bone following ovarian hormone deficiency was the particular focus in this study.
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STUDY DESIGN
Experimental design in this study was a 2x4 completely randomized block design.
Eighty-four weanling female Sprague-Dawley rats were randomized into four dietary iron
regimens (calculated to be 6 ppm, 12 ppm, 35 ppm or 150 ppm as iron citrate) and two
surgical treatments (sham-operated or ovariectomized). Animals were pair fed to the 150
ppm sham group and when necessary were fed less to match for weight. Surgery was
performed at skeletal maturity after 15 weeks of dietary treatment. Necropsy was
performed 12 weeks following surgery with collection of urine, blood., organs and bones
for analyses. Analyses ofnutrition and bone status were performed. Experimental
procedures were approved by the Oklahoma State University Animal Use and Care Board.
Statistical analysis ofdata was performed using SAS (version 7.0, SAS Institute, Cary,
NC). Four animals were excluded from analyses secondary to obvious health problems
discovered during the experiment.
LIST OF HYPOTHESES
This study advances the following hypotheses:
I) There will be no significant differences by diet or ovarian hormone status (OHS) group
and no significant diet x OHS interaction in final body weight.
2) There will be no significant differences by diet or OHS group and no significant diet x
OHS interaction in bone metabolism as measured by:
a) insulin-like growth factor I (lGF-I) at necropsy
b) alkaline phosphatase extracted from bone (ALP) at necropsy
c) urinary excretion of calcium. (Ca) pre-surgery and at necropsy
d) urinary excretion ofmagnesium (Mg) pre-surgery and at necropsy
e) urinary excretion ofphosphorous (P) pre-surgery and at necropsy
f) urinary excretion offree deoxypyridinoline (DPD) pre-surgery and at necropsy
g) urinary excretion of hydroxyproline pre-surgery and at necropsy.
3) There will be no significant differences by diet or ORS group and no significant diet x
ORS interaction in bone size at necropsy as measured by:
a) femur length
b) femur area
4) There will be no significant differences by diet or ORS group and no significant diet x
ORS interaction in bone density at necropsy as measured by:
a) dual energy x-ray absorptiometry (DXA)
b) Archimedes' principle.
5) There will be no significant differences by diet or ORS group and no significant diet x
ORS interaction in bone mineral content at necropsy as measured by:
a) dual energy x-ray absorptiometry (DXA).
6) There will be no significant differences by diet or ORS group and no significant diet x
DRS interaction in bone strength at necropsy as measured by:




REVIEW OF THE LITERATURE
1be following sections review literature focusing on parameters ofbone
metabolism and indicators ofbone metabolism. Literature discussing measurements of
bone parameters and the rat model are also reviewed.
Bone metabolism has been shown to be affected by multiple factors. While not an
all-inclusive list, mechanical strain or load bearing, genetics, hormonal status, nutrition,
and disease state are among those factors. In addition, these factors often affect bone in
combination.
BONE MASS
Load Bearing. Load bearing has been correlated with bone mass. In a human
population-based study of39 girls and 48 boys with a mean age of 15.1 years (Duppe et
al. 1997), total body bone mineral content but not total body bone mineral density at ages
4 and 6 years and in adolescence as measured by DXA was found to be predicted by
childhood weight. The authors concluded that these findings suggest skeletal envelope is
more influenced by body weight than is skeletal density.
According to Heaney (1996), body weight is the single largest detenninant of bone
density in adult humans and accounts for approximately one-half of the population level
variance. In fact, fracture risk in obese women was cited to be approximately one-third
that ofnonnal weight women, and excessively lean women were purported to have high
fracture risk. These differences were attributed by Heaney to increased mechanical
loading seen with increased body weight as well extra fat padding present in obese women
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and unknown factors which cause bone in obese women to behave "as ifit had a lower set
point for the reference level ofbending under load".
In a prospective study ofmale Sprague-Dawley rats (Mosley et al. 1997) weighing
250 to 300 grams, treatment animals were anesthetized and mechanical load of-0.0005,
-0.001, -0.002, -0.003 or -0.004 compressive dynamic strain was applied to the ulnae via
padded cups attached to low friction bearings in a servohydraulic material testing machine.
Mechanical loading was applied on days one through five and eight through twelve of the
experiment. Mechanical loading produced strain-dependent shorter ulnar length in all
treatment groups compared to controls. No significant effect was seen in the -0.0005
treatment group and a negative effect on ulnar mass were seen and -0.001 and -0.002
treatment groups versus control rats. Significantly increased ulnar mass was found in the -
0.003 and -0.004 treatment rats versus control rats. Mineral apposition rates in these two
groups were increased on the lateral bone face, and the medial face was converted from
bone resorption to formation. The authors conclude that mechanical loading affects both
bone curvature and mass.
Peng et al. (1994) immobilized the right hind leg of33 (28 male and five female)
10-week-old S.D. rats for three weeks by placing the limb in plantar flexion in a plaster
east. Cast was checked daily and replaced weekly or as needed. On three point bending
testing, femora of immobilized animals exlubited lower neck strength and energy
absorption versus control rats. Femur and tibia ash weights were significantly lower in
immobilized animals compared to control animals. By histological examination,
immobilized animals were found to have significantly lower trabecular bone, significantly
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lower bone are~ and significantly greater marrow cavity versus control animals.
Genetics. It bas been shown that genetics may influence the development ofpeak
bone mass. In a study of 31 fourteen-year-old Caucasian girls and their biological parents.
Matkovic et aI. (1990) investigated hereditary influences on bone by comparing the girls'
and parents' bone mass. Positive correlations between mean parent and daughter values
were found for metacarpal length (r = 0.46) as measured by standardized x-rays and
needle-tipped caliper, distal forearm density (r = 0.72) and cross-sectional area oftbe
metacarpal (r = 0.73) as measured by radiogrammetry and single- and dual-pboton
absorptiometry. The authors concluded genetics influenced bone growth and
consolidation in adolescent girls.
In a study ofaduh same sex fraternal (mean age 40 years) and identical twins
(mean age 47 years), Pocock et al. (1987) investigated hereditary influences on bone. No
differences in bone mineral content or bone mineral density ofthe right proximal femur
(femoral neck, Ward's triangle, and trochanter) or lumbar spine as measured by dual
photon absorptiometry were seen between participants and age-matched controls. No
differences in BMC or BMD ofeither site were seen within any ofthe twin pairs.
Correlations of lumbar and proximal femur BMD and forearm BMC were all higher for
the identical versus fraternal twin. pairs. The authors concluded spinal and proximal
femoral as well as upper limb bone mass had a significant genetic component and
emphasized family history as an important factor in identifYing individuals at risk for
clinical bone disease.
j Estrogen Deficiency. Many studies have demonstrated the deleterious effects of
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estrogen deficiency on bone. Clark. and Tarttelin (1982) sham-operated or ovariectomized
rats at ages two days (D2), four weeks (W4), and seven weeks (W7). One W7 ovx group
was injected with estradiol benzoate 2f.Lg daily, and one control group was injected with
carner solvent daily. Animals were given ad hoitum access to tap water and pelleted rat
diet. Nose-anal lengths were measured with animals anesthetized, and body weights were
recorded after sacrifice. Final body weight and nose-anal length were greater in W4 and
W7 compared to sham animals. No significant differences in final body weight or nose-
anal length were noted between D2 and sham animals. No significant differences in final
body weight or nose-anal length were noted between estrogen treated and sham animals.
No other bone measurements were performed. The authors concluded that ovariectomy
stimulated skeletal growth and estrogen treatment ofovariectomized animals prevented
this effect.
./ In a study of34 Sprague-Dawley rats randomized into sham or ovx treatment at
six months of age, animals were pair fed a natural diet containing 0.1% calcium and 0.3%
phosphorous in the amount of 15 grams per day. Plasma dialyzable calcium, plasma
complexed calcium, urine calcium excretion, and plasma phosphorous were elevated in the
ovx versus sham animals at one, three, and six weeks post-surgery. Bone mineral density
and bone mineral content as measured by DXA decreased in both ovariectomized and
sham-operated animals during the study, but significantly more so in the ovariectomized
group (Dick et at 1996).
Goulding et at (1996) deep labeled female albino WlStar rat skeletons with 4.5Ca,
and maintained the animals on a stock diet containing 1.0% calcium for four weeks to
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allow freely exchangeable 4~Ca to be eliminated. Animals were then transferred to a
hydroxyproline-free casein treatment diet providing 0.1% Ca and randomized into surgical
treatments ofsham-operated, sham-operated plus estradiol, hysterectomized,
hysterectomized plus estradiol, ovariectomized, ovariectomized plus estradiol,
hysterectomized/ovariectomized, and hysterectomized/ovariectomized plus estradiol The
ovariectomized rats (n=eight, final body weight 293.1 ± 9.4 g) exhibited lower density
determined by displacement and DXA bone mineral density, greater femur length, and
lower femur Ca and 45Ca content. The ovariectomized group also exhibited greater
urinary excretion of 4sCa at weeks one and four post-surgery; greater urinary excretion of
hydroxyproline at weeks one, two and four post-surgery; and greater urinary excretion of
DPD crosslinks at week four post-surgery. The ovariectomized plus estradiol did not
exhibit these effects. Urinary DPD and hydroxyproline excretion showed a high
correlation (r = 0.786). The authors concluded that ovariectomized rats lost bone due to
resorption exceeding formation, and administration ofestradiol prevented this effect.
In two studies (n=40 and n=80) of mature (100 ± 5 days ofage) Sprague-Dawley
rats, Bagi et aI. (1996 and 1997) pair fed ovx to sham animals with standard laboratory
diet. The ovx animals were fOWld to have greater total bone area and total bone mineral
content and similar femur bone area and mineral content but lower femoral bone mineral
density as measured by DXA compared to the sham-operated animals. Ovariectomized
animals were also found to have lower trabecular and cortical bone compared to time-
matched sham animals. In the second study, nodal analysis of remaining trabecular bone in
ovx animals revealed adversely altered architecture compared to sham animals. Femoral
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strength as determined by mechanical testing was greater in both sham and ovx groups at
study end compared to baseline. However, femoral uhimate strength was significantly
greater in sham compared to ovx animals at four and eight weeks post-surgery; and
femoral stiffiless significantly greater in sham compared to ovx animals at four, eight, and
12 weeks post-surgery. The authors concluded that ovariectomy induced unfavorable
changes in rat bone.
,/10 a study by Sims et at (1996), 126 Sprague-Dawley rats were ovariectomized or
sham-operated at 6.5 months ofage and fed 15 g1day commercial rat chow containing
0.76% calcium, 0.46% available phosphorous, and 2000 IU/kg vitamin D;l Ovx rats
showed significantly greater urinary excretion ofhydroxyproline and serum phosphate
compared to sham from six days post-surgery to the end ofthe study at 42 days post-
surgery. On femoral histomorphometry, ovx animals exhibited greater femoral bone
resorption and lower trabecular number compared to sham animals.
In the rat tibia, Wronski et ai. (1985) demonstrated greater bone fonnation rates
with higher numbers ofosteoblasts, percent osteoblast surface, longitudinal bone growth,
percent forming bone surface, and calcification rate. Greater bone resorption was also
seen with higher numbers ofosteoclasts and percent osteoclast surface. Despite the
greater bone formation as well as resorption rates, net bone loss with smaller trabecular
area was found in Sprague-Dawley rats (n=nine) ovariectomized at 75 days ofage
compared to control rats. All animals were ad hbitum fed rat laboratory chow.
Ovariectomized rat weight at study end was 298.4 ± 26.3 g.
Results ofPeng et al.'s (1994) study showed lower femoral neck and tibia st.rength
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in mechanical failure load and three-point bending tests, respectively, in Sprague-Dawley
rats (n=14) ovariectomized at 12 weeks ofage versus sham rats. Energy absorption of the
femoral neck and trabecular bone volume were also lower and length was significantly
greater in ovx versus sham rats. Rats were killed six weeks post-surgery. Diet
components were not listed.
Li et al. (1997) studied ovariectomized Spragu.e-Dawley rats surgically treated at
90 days ofage and weighing 506 ± 19 g at one year post-surgery. Ovx rats were pair fed
to sham rats a diet containing 0.95% Ca and 0.67% PO•. Femoral cancellous bone was
lower in ovx and relatively stable in sham animals at 30, 60, 90, 180, 270 and 360 days
post-surgery. Percent osteoclast, osteoblast surface, mineralizing surface, mineral
apposition rate, and bone formation rate were higher in ovx than sham at the above
mentioned time periods. Ovx rats exhibited lower trabecular number begimring at 60 days
post-surgery, greater trabecular separation beginning at 30 days post-surgery, cortical
thinning beginning at 60 days post-surgery, and negative bone balance at one year post-
surgery compared to sham rats. The authors concluded that ovariectomy induced loss of
both cortical and trabecular bone.
In a study of 150 WlStar rats randomized into three surgical treatments (sham, ovx,
and ovx plus estradiol) at approximately 142 days of age, ovx animals were pair fed to ad
libitum fed sham animals a standard diet (1.1 % Ca, 0.8% P and 2 ill vitamin D]/g) based
on AIN-76 recommendations or standard diet modified to contain low calciwn (0.2%
calcium, 0.8 % P and 2 IU vitamin D/g). Beginning at one month post-surgery and
continuing until study end at nine months post-surgery, both ovx and ovx + LCD groups
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weighed significantly more than sham and sham + LCD groups. First through fourth
lumbar vertebrae (LI-U); femoral neck, femoral mid-shaft, and distal femoral metaphysis
DXA BMD; and total femoral, femoral mid-shaft, and distal femoral metaphysis BMC
were lower in ovx and ovx plus low calcium diet compared to all other groups at three,
six, and nine months post-surgery. DXA total femoral area was greater in ovx and ovx
plus low calcium diet compared to all other groups at the same time points. Compressive
strength and compressive stiffness ofLl vertebra as measured by a biomechanical testing
machine were found to be significantly lower in ovx and ovx plus low calcium diet versus
sham animals at the same time points post-surgery. Femoral torsional strength and
femoral torsional stiffness were greatest in ovx and ovx plus low calcium diet at six and
nine months post-surgery. These effects were not seen in the ovx plus estradiol group.
The authors concluded that ovariectomy and ovariectomy in conjunction low calcium diet
adversely impacted bone metabolism, and estrogen replacement prevented the adverse
effects of ovx. They suggested femoral biomechanical testing was not significantly
impacted by ovariectomy as cortical bone provided the majority oflong bone stability and
cortical bone was not as affected by ovariectomy as was trabecular bone (Jiang et al.
1997).
In a study of 150 Sprague-Dawley rats ovariectomized or sham operated at 12
weeks ofage and ad libitum fed commercial laboratory food, Peng et aI. (1997)
demonstrated greater femur length and marrow area at the distal one-third ofthe femur in
ovx versus sham animals beginning at approximately 5 weeks post-surgery. Anima1s were
injected with 45Ca2+ three days prior to necropsy, and ovx animals exhibited increased tibial
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incorporation of '4SQi2+ from weeks 4 to 16 post-surgery compared to sham animals. Both
groups exhibited decreased percent femur trabecular bone volume over time, and ovx had
significantly less volume than sham rats. Osteoclast number in the femur was greater in
ovx versus sham animals from weeks two to 28 post-surgery with a dramatic increase at
two weeks post-surgery. Maximal femoral load did not increase from baseline in ovx but
did in control animals. Humerus torque increased over time in both groups, and was
greater in ovx than sham animals. The authors concluded that ovariectomy increased bone
metabolism producing increased periosteal apposition and endocortical resorption that
sometimes resulted in cortical strength compensating for trabecular loss.
In a study of 110 Sprague-Dawley rats treated surgically at 90 days of age, ovx
rats were pair fed a standard diet containing 1% Ca and 0.74% P to sham and ovx plus
estradiol rats. Ovx plus estradiol rats were treated at three months post-surgery with 17p.
estradiol 10 J.1g1kg body weight for five days. Double labeling of bone forming sites was
performed with intraperitoneal injection ofoxytetracycline at six and two days prior to
necropsy. On bone histomorphometry, ovx animals had a significantly lower trabecular
bone volume at one, three and six months post-surgery versus sham and at three months
post-surgery versus estrogen-treated ovx animals. Ovx animals exhibited greater bone
formation as measured by percent double labeled surface and bone formation rate.
Greater formation was also seen with tibial osteoblastic cells cultured from ovx animals
having higher proliferation rates as measured by [3H] thymidine incorporation and ceD
numbers compared to sham animals. Greater resorption as measured by percent
osteoclast surface was also demonstrated compared to estrogen-treated ovariectomized
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rats and control rats at the above mentioned time periods. Bone resorption as measured
by osteoclast number was significantly greater in ovx versus sham rats at one and six
months post-surgery. The authors concluded that ovariectomy induced increased
endosteal bone formation was related to the increased proliferation ofosteoblast precursor
cells (Modrowski et ai. 1993).
In a study of48 SD rats sham-operated or ovariectomized at two to three months
of age, animals were ad libitum fed a non-purified diet containing 0.8% calcium and given
free access to water containing zero added, two, six or 18 g sodium chloride/liter.
Twenty-four hour urine samples were collected. at times 0 (10 days post-surgery and
before beginning treatment drinking water), two, four, six, 10, and 12 months. At four
and six months of treatment and controlling for sodium effect, ovx animals were
significantly heavier than sham animals whereas at 10 and 12 months of treatment no
significant differences were noted in body weight. Urine calcium excretion was greater at
six and 12 months oftreatment in ovx versus sham animals when controlled for the
sodium effect. Urinary excretion ofhydroxypro1ine controlled for effect of sodium was
greater in ovx compared to sham animals at time O. Femur weight was significantly lower
in ovx versus sham animals when controlled for sodium effect. Bone calcium content was
affected significantly by sodium intake but more so by ovariectomy. The authors
concluded. that these results suggested the rapid bone loss seen immediately and increased
body weight resulting after ovariectomy in rats did not persist. They also concluded that
while sodium exerted a small but significant affect on bone calcium content ovariectomy
exerted an overriding affect (Chan and Swarminatban 1998).
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To date, results ofstudies seeking to determine if load bearing offsets estrogen
deficiency induced bone loss have been conflicting. Wronksi et a1. (1987) found in
Sprague-Dawley rats ovariectomized or sham. operated at 78 days of age decreased tibial
trabecular bone volume both in obese and weight-matched animals compared to control
animals. Additionally, tibial trabecular bone volume was significantly less in weight-
matched versus obese ovariectomized rats. Westerlind et a1. (1997) found in
ovariectomized Sprague-Dawley rats treated surgically at 90 days ofage that the more
load bearing portion of the femur (epiphysis) shows less cancellous bone loss than the
metaphysis which bears less mechanical strain. In addition, load bearing bones versus non-
load bearing bones showed decreased loss. Estrogen treatment ofovariectomized rats
decreased loss in unloaded bones and prevented loss in loaded bones. In contrast, in a
study of Sprague-Dawley rats (weight 225-250g at surgery), Roudebush et aI. (1993)
found significantly lower femur bone mineral density in ovariectomized compared to sham
animals even when ovariectomized animals were significantly heavier than sham animals.
Protection from osteopenia was demonstrated only with estrogen replacement.
ROLE OF NUTRIENTS IN BONE FORMATION
Background. Information on the beneficial role ofdietary intake ofcalciwn and
vitamin D is widely available (Anderson 1991, Henry and Nonnan 1984). A review ofaU
such infonnation and studies is beyond the scope ofthis thesis. Adequate ascorbic acid,
required in the hydroxylation ofproline into hydroxyproline in the manufacture ofbone
matrix collagen, intake is also accepted as necessary for proper bone metabolism (Englard
and Seifter 1986). Dietary intake ofother vitamins and minerals and their impact on bone
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have been less extensively researched.
Collagen. Collagen is one of the major proteins ofconnective tissues and is
composed ofthree polypeptide units containing multiple amino acids. The hydroxy amino
acids present in the polypeptide chains, hydroxyproline and hydroxylysine~ are found
almost exclusively in collagen. It has been determined that iron and copper are integral in
post-translational modification oftype I collagen, the connective tissue foundation of
bone. Iron plays a role in the hydroxylation of specific prolyl and lysyl residues of
collagen, and copper functions in collagen crosslink formation. Copper, but not iron,
deficiency has been demonstrated to impair crosslink formation (O'Dell 1981) and impair
mechanical strength ofbone (Jonas et al. 1993).
Copper. In a study of 14 weanling Wistar rats, animals randomized to a copper
deficient (0.4 mg Cu/kg) diet were pair fed to animals fed a copper sufficient (11.0 mg
Cu/kg) diet. Animal weights were not significantly different at necropsy. Femora did not
differ in length, external mid-shaft diameter~ or mid-shaft cortical thickness. On torsional
loading, copper deficient animals bad significantly lower maximal femoral sustained
torque, ultimate angular deformation and toughness in torsional loading until fracture
versus copper sufficient animals. No difference in femoral torsional stiffness was seen.
Femoral calcium content and percent bone ash did not differ between the two groups. The
authors concluded the above femoral changes were likely related to changes in the
collagen matrix resulting from the copper deficiency (Jonas et aL 1993).
[ron. Iron, the nutrient offocus in this research project, has several known
biological roles. Its functions in oxygen transport, cell growth and oxidative metabolism
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are well established. Its potential role in bone metabolism bas not been fully explored.
Angus et aI. (1988) performed a study of 160 (89 pre-menopausal and 71 post-
menopausal) Caucasian Australian women aged 23 to 75 years. Menopausal status was
detennined by serum measurement offollide stimulating honnone, luteinizing honnone,
and. estradiol. A Lunar DP3 dual photon absorptiometer was used to measure bone
mineral density (g1cm2) ofthe right proximal femur and second through fourth lumbar
vertebrae (L2-L4). A single photon densitometer was used to measure foreann BMC
(U/cm). Participants completed a four day food record including a weekend as well as
semi-quantitative food frequency questionnaire to detennine usual nutrient intake. Food
records were analyzed using a computerized dietary analysis program based on the British
tables of food composition. Calcium intake in childhood was estimated with a
retrospective questionnaire. Current mean calcium intake (738 ± 32 rngIday in
premenopausal and 698 ± 37 mg/day in postmenopausal women) as analyzed from four
day food records fell below recommendations for both pre- and postmenopausal women.
Current mean iron intake (10.9 ± 0.4 mg/day in premenopausal and 9.9 ± 0.4 mgIday in
postmenopausal women) as analyzed from four day food records fell below
recommendations for premenopausal and exceeded recommendations for postmenopausal
women. The authors found no correlation between current calcium or calcium plus
vitamin D intake and bone mass. However, results suggested a relationship between early
calcium intake and forearm BMC. A positive correlation between forearm bone mineral
content and current iron, zinc, and magnesium intake as determined by food record
analysis was demonstrated in pre-menopausal women. Current iron intake as determined
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by food record analysis was also found to be an independent predictor offemoral neck
bone mass in pre-menopausal women. The authors concluded that prospective studies are
required to further assess the relationship between bone mass and mineral deficiencies.
J Iron Deficiency. Iron deficiency has been associated with ahered metabolism of
other nutrients. In a study ofrecently weaned (four weeks of age) 84 male albino Wistar
rats, Pallares et°al. (1996) found decreased serum hemoglobin and serum iron and
decreased iron concentration in liver and femur in iron deficient versus control animals.
Decreased calcium concentration in the femur, sternum, and liver; increased phosphorous
concentration in the liver and femur; and increased magnesium concentration in the liver
were also found in iron deficient versus control animals. No significant differences were
seen between iron deficient and control animals in serum calcium, phosphorous or
magnesium concentrations. With iron replacement with ferrous ascorbate and ferrous
sulfate, tissue concentrations of iron, calcium, phosphorous and magnesium approached
normal AnimaJs given iron replacement in the form ferric citrate continued to exhibit
reduced magnesium absorption and low femoral calcium and phosphorous concentrations,
suggesting the ferrous ascorbate and ferrous sulfate were more effectively absorbed than
the ferric citrate. No bone measures besides mineral content were performed. The
authors concluded that iron deficiency altered the status ofcalcium. phosphorous and
magnesium and that iron was involved in bone mineralization.
In a study of94 weanling male albino Wistar rats, animals were fed a diet adhering
to AIN-76 recommendations for all nutrients except iron. The treatment diet was altered
to contain no added iron and was analyzed as containing 4.4 mg kg'l iron. Liver, spleen,
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sternum, and femur iron was lower in treatment diet animals versus control diet animals
for all time points measured (10, 20, 30 and 40 days of treatment diet consumption).
Treatment diet animals showed increased intestinal calcium, phosphorous, and magnesium
absorption with decreased or unchanged balance. Liver calcium., phosphorous, and
magnesium concentrations were significantly greater at 40 days oftreatment diet
consumption in iron deficient compared to control animals. Spleen calcium, phosphorous,
and magnesium concentrations were all greater in treatment versus control animals after
40 days ofdiet consumption, calcium and phosphorous significantly so. Sternum ca1ciwn,
phosphorous, and magnesium concentrations showed trends of being lower after 40 days
ofdiet consumption in treatment compared to control rats. Femur calcium, phosphorous,
and magnesium content and serum calcium concentration were lower at all time periods
measured compared to control rats. No bone measures besides mineral content were
performed. Serum cortisol and parathyroid hormone (PTH) were significantly greater
after 40 days ofdietary treatment in iron deficient compared to control animals. The
authors concluded iron deficiency anemia altered the metabolism ofcalcium., phosphorous,
and magnesium with increased intestinal absorption and changed metabolic utilization
arising from honnonal changes associated with the anemia (Campos et al 1998).
~okoi et al. (1990) fed fifteen young male Wistar rats (initial weight - 1DOg) a
control diet (analyzed to contain 128 JJ.glg iron citrate) or iron deficient diet (analyzed to
contain 5.9 IJ,glg iron citrate). Iron concentration in blood, brain, lung, heart, liver,
spleen, kidney, testis, femoral muscle, and tibia were significantly lower in treatment
compared to control rats. Blood calcium and copper were significantly higher while
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magnesium. and zinc were significantly lower in treatment versus control animals. Liver
calcium and copper were significantly greater in treatment rats compared to control rats.
Manganese concentrations were significantly higher in iron deficient animals versus
controls in the brain, heart, spleen, kidney, testis, femoral muscle and tibia. No other bone
measures were performed. Ratio ofheart to body weight was significantly greater in
treatment animals compared to control animals.
Iron deficiency has been associated with decreased bone fracture healing. In a
study of 120 Sprague-Dawley rats (weight 300g), Rothman et at (1971) randomized the
animals into a control group fed a diet ofpowdered milk with a multiple vitamin
supplement and distilled water or a treatment group fed the same diet plus muhiple
vitamin supplement without iron. No mineral mix was listed. The treatment group was
phlebotomized weekly for fom weeks to produce anemia. One week fo Uowing the fourth
phlebotomy, both groups underwent a surgical fracture of the mid-shaft of the right fibula..
Hematocrit and serum iron measures demonstrated anemia in the treatment group. No
difference in serum calci~ phosphorous, alkaline phosphatase (ALP), albumin, uric acid,
and serum glutamic-oxaloacetic transaminase (currently termed aspartate aminotransferase
or AST) was seen between anemic and control rats. The treatment group was found to
have lower fibular tensile strength as well as fracture non-union and retardation offracture
healing versus control rats at three, six., and eight weeks post-fracture.
In a study of30 male white New Zealand rabbits (weight two to three kg), a
surgical fibular fracture was produced. Animals were than randomized into three groups:
control group (phlebotomized and whole blood re-injected), normovolemic treatment
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(ph1ebotimized, red cells discard~ and equal volume plasma re-injected), hypovolemic
treatment (phlebotimized). Serum hematocrit was lower in both treatment groups
compared to control group. No other serum biochemical tests were performed. Lower
fibular strength as measured by modulus ofelasticity and delayed fracture healing as seen
on roentgenogram and in histological testing was reported in the hypovolemic treatment
versus nonnovolemic treatment and control animals. The authors concluded that
hypovolemic iron deficiency anemia was associated with delayed fracture healing and
possi~ly decreased tissue oxygen delivery whereas normovolemic iron deficiency anemia
was not associated with delayed fracture healing possibly due to compensation
mechanisms, Le. increased cardiac output, nonnalizing tissue oxygen delivery (Heppenstall
and Brighton 1977).
In a study ofweanling female and male wild-type BALB/cj mice, mice
heterozygotic for hypotransferrinemia, and mice homozygotic for hypotransferrinemia,
animals were ad libitum fed for five weeks purified diets based on AIN-93
recommendations containing either adequate (35mglkg) iron as ferric citrate or no added
iron (Fe-). Five groups resulted: wild-type iron adequate (+/+ Fe+), wild-type iron
deficient (+/+ Fe-), heterozygote iron adequate (+/hpx Fe+), heterozygote iron deficient
(+/hpx Fe-) and homozygote iron adequate (hpx/hpx Fe+). A homozygotic iron deficient
group was not implemented as the researchers felt the animals would not survive. The
bpx/hpx animals were given weekly intraperitoneal injections ofhuman apo-transferrin
until 2 weeks prior to kill Animals were given free access to distilled water. The
bpxlbpx group was anemic with significantly lower serwn transferrin, plasma iron and
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percent hematocrit than +/+ Fe+- and +/hpx Fe+- groups. Calculated cross-section femoral
area and moment of inertia as measured by three-point bending were significantly lower in
female hpx/hpx Fe+- versus +lhpx Fe+ and in male hpx/hpx Fe+- group as compared to +/+
Fe+-. Femoral failure load and extrinsic stifihess were significantly lower whereas ultimate
stress and modulus ofelasticity were higher in hpx/hpx mice compared with +/+ mice.
The higher ultimate stress and modulus ofelasticity in the hpx/hpx group was felt to be
due to small femur size. The hpx/hpx mice bad the highest total tibial iron and calcium
content as well as the greatest tibial wet weight. No dietary iron main effects were seen in
measures ofbone properties. The authors concluded their results suggested an association
between transferrin and bone mineralization and raised questions about iron deficiency
affecting bone mineralization [Malecki et al. 2000].,
Iron Excess. Excess dietary iron has also been associated with altered metabolism
of nutrients. In a study of96 male Sprague-Dawley rats (no age or weight given), animals
maintained on excess iron diets chronically had decreased tibial zinc retention compared to
animals fed excess iron in only one meal. Rats fed 3042 J-ig iron/g diet had significantly
lower final body weight, daily food intake, and higher ratio of liver to body weight.
Kidney and liver iron levels were significantly higher in the 3042 Jig iron/g diet group than
in all other groups. Tibia copper levels were significantly greater while liver copper levels
were significantly lower in the excess iron group compared to the control group. Kidney
and tibia zinc levels tended to be lower but not significantly so (Storey and Greger 1987).
In a study of53 African males diagnosed with skeletal disorders (vertebral
osteoporosis, femoral neck fracture, osteonecrosis of the femoral head), participants were
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divided into two groups based on number ofhemosiderin-ladeo macropbages per mm?
seen on iliac crest bone biopsy: iron overloaded (+Fe, 0=38, median age 44 years) and
non-iron overloaded (-Fe, n=15, median age 37). Dietary iron overload. in this population
was caused by consumption of traditional home-brewed beer prepared in metal drums or
iron pots; iron from the vessel leaches into the brew as the pH of the beer decreases during
fermentation. Control values for structural and static bone turnover were obtained from
43 age-matched black males (34 cadavers of individuals who had died suddenly but
previously had been healthy and 9 limb surgery patients). Control values for tetracycline-
based variables were obtained from 8 ofthe limb surgery patients. Alcohol consumption
was significantly higher in the -Fe group versus the +Fe and control groups. The +Fe
group had significantly higher serum ferritin and transferrin than the -Fe and control
groups, and significantly higher serum iron but lower leukocyte ascorbic acid than the
controls. Utilizing a tetracycline double labeled iliac crest bone biopsy, it was found that
both the +Fe and -Fe groups had significantly smaller trabecular thickness and greater
trabecular separation while +Fe also had significantly lower trabecular number (number of
trabeculae intersected per mm straight line) compared to controls. Erosion depth was
significantly greater in +Fe versus -Fe and control groups, and significantly greater in the
+Fe group versus -Fe group. Iron granules in iliac crest bone correlated negatively with
trabecular number and positively with trabecular spacing and erosion depth The authors
concluded that osteoporosis was associated with dietary iron overload and resulted from a
combination ofalcohol abuse, iron overload., and hypovitaminosis C. They also concluded
that further research is necessary to separate the effects of iron overload and
-
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hypovitaminosis C on bone metabolism (Schnitzler et al. 1994).
Excess iron has been associated with adverse bone resuhs. In Storey and Greger's
(1987) study, rats fed 3042 f,lg iron/g diet had lower tibia weights and higher tibia iron
concentration than controls. In female long white pigs 76 to 91 days ofage given 300 rng
dextran iron per day intramuscularly for 36 days, plasma iron was greater in treated versus
control pigs at days 21 and 36. Liver weight and liver iron were significantly greater in
treated animals compared to control animals. SOOT (AST) and SGPT (ALT) were
greater in treated compared to control pigs, SOOT (AST) significantly so. No differences
in plasma calcium, phosphate, magnesium or alkaline phosphatase (ALP) were seen except
for serum calcium being lower at day 21 in treated versus control pigs. No differences in
urine calcium, phosphate, and hydroxyproline were seen. No differences in bone calcium,
phosphate, magnesium or ash content was seen. However, metatarsal bone iron content
was significantly higher in treated versus control animals. A significant correlation was
seen between liver and bone iron. Osteoid surface was lower in treated compared to
control pigs. Also, appositional rate and mean wall thickness were lower, and reversal
surfaces greater in treated versus control pigs. The authors hypothesized that despite
adverse effects on bone metabolism indicators no decrease in trabecular volume or bone
ash content was seen because study length was too short (de Vernejoul et aI. 1984).
In a study of 106 male and female humans with docwnented chronic liver disease
(39 with alcoholic liver disease, 23 with hemochromatosis, 25 with chronic active
hepatitis, and 19 with cholestatic liver diseases), participants were divided into cirrhotic
and non-cirrhotic groups. Control data for BMD was obtained from 113 healthy
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volunteers matched for age, sex, and menopausal status. Forty ofthe controls underwent
bone biopsy. All subjects bad significantly lower mean cancellous bone area compared to
controls. Mean bone iron concentration was 2.5 times higher in both groups than in
controls, and 22 of the participants had bone iron concentrations greater than the
reference range upper limit (>36mg/kg dry bone). Bone aluminum and copper did not
differ significantly in participant groups versus control group. Forty ofthe participants
}\Tere osteoporotic as measured by bone biopsy or non-invasive criteria, and 23 of these 40
exhibited low bone fonnation rates. Additionally, 34 participants had diminished bone
formation although not frank osteoporosis. A weak negative correlation was found
between bone iron and bone formation. Participant bone area was significantly lower and
mineralization lag time significantly greater compared to controls. Forearm mineral
content as measured by single photon absorptiometry and vertebral BMD as measured by
single energy computed tomography was significantly lower in the cirrhotic versus non-
cirrhotic group. In an in vitro segment of the study, the rat osteosarcoma cen line UMR
106-01was cultured. Only very high (400 ,urnoVliter) iron concentration affected in vitro
osteoblast function and proliferation, but testing with prolonged exposure to lower iron
concentrations was not performed (Diamond et at 1991).
In a study of22 human males aged 35 to 62 years diagnosed with idiopathic
hemacbromatosis (Ill) by liver biopsy, five were hypogonadal (H), nine eugonadal non-
venesected (EN), and eight eugonadal venesected (BV). Healthy ambulatory men (n=20)
undergoing elective orthopedic procedures acted as controls for serum biochemistry,
spinal radiology, spinal quantitative computed tomography, single photon absorptiometry
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ofthe forearm, and bone histomorphometry. Serum ferrit~ aspartate aminotransferase
CAST), and alanine aminotransferase (ALT) was significantly higher in H than EN, EV,
and contro~ and significantly higher in EN than EV and control Serum calcium was
significantly higher in all participants compared to controls. Serum inorganic phosphate
was higher in H compared to EN. Urine hydroxyproline excretion adjusted for creatinine
was significantly higher in H versus all other groups. Radial bone density as measured by
iodine-125 photon absorptiometry and trabecular bone volume as measured by double
tetracycline labeled iliac crest bone biopsy were significantly decreased in H compared to
all other groups, and vertebral bone density as measured by single and dual energy
computed tomography (Cn was significantly decreased in H versus controls. By iliac
crest bone biopsy, percent osteoclast surface and number were significantly greater in H
compared to all other groups. Mineral apposition rate as measured by bone biopsy was
significantly lower in all participants compared to controls, and significantly lower in EN
versus EV. Percent mineralized surface and bone fonnation rate as measured by bone
biopsy was significantly lower in EN versus EV and control groups. Mineralization lag
time as measured by bone biopsy was significantly greater in both eugonadal groups
versus control group. Ten of the 22 participants exhibited osteoporosis as measured by
CT. The authors concluded that bone density was significantly lower in patients with IH,
especially in conjunction with hypogonadism (Diamond et at 1989).
Conte et al (1989) compared six human males (mean age 48.8 ± 5.5 years) with
primary hemacbromatosis (PH) to eight human males (mean age 49.5 ± 7.9 years) with
alcoholic cirrhosis (AC). A group of 30 healthy male subjects served as controls (mean
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age 48.S ± 8.3 years). Plasma ALP was significantly elevated in AC versus controls. No
differences in plasma or urine calcium and phosphate were seen between PH and AC
groups and controls. PH and AC groups bad significantly elevated creatinine-corrected
urinary hydroxyproline excretion versus controls. PH had significantly d reased forearm
bone mineral density and cortical osteopenia as measured by iodine-125 photon
absorptiometry versus AC and controls. Transiliac crest lxme specimens indicate
trabecular osteoporosis in the PH group only.
In a case study ofa 48-year-old French Caucasian male diagnosed with primary
hemachromatosis by liver biopsy, the patient presented initially for treatment ofmuhiple
spontaneous vertebral fractures. The patient was found to have elevated alkaline
phosphatase activity but alcohol intake ofless than 40 g1day. Testosterone level was
significantly lower than normal Urinary hydroxyproline excretion corrected for creatinine
was elevated. Thyroid status was normal. Osteoblast and osteoclast activity were both
lower than nonna!. Iliac crest trabecular bone volume as measured by biopsy was
significantly lower and was associated with lower cortical bone thickness. Bone mineral
content of the lumbar spine and femoral neck as measured by DXA were low. The
authors concluded that the osteoporosis in IH is likely due to excessive bone resorption
and inadequate bone formation with exact mechanisms unclear and multifactorial, e.g.,
hyperparathyroidism, hypogonadism, diabetes mellitus, vitamin D deficiency, vitamin C
deficiency, and iron excess (Duquenne et al. 1996).
INDICATORS OF BONE METABOLISM
Insulin-like growth factor I. Insulin-like growth factor I QGF-I) is an anabolic
-
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hormone which promotes cell proliferation and differentiation in many different cells.
Bone is one target organ ofIGF-I, and IGF-I is believed to participate in skeletal growth,
regulation and bone metabolism.
In a study of95-day-old female Sprague-Dawley rats. animals were fed a standard
laboratory diet containing 0.4% calcium, 0.3% phosphorous and 3.0 units vitamin Dig
diet. Animals were divided into four groups: sham plus solvent vehicle daily (sham), ovx
plus solvent vehicle daily (ovx), ovx plus 200 ng 17f}-estradioVkg body weight per day
(ovx LD) and ovx plus 5000ng 17f}-estradioVkg body weight daily for the first 12 days
then alternating with solvent vehicle every other day thereafter (ovx HD). Animals were
killed 35 days post-surgery. Final body weight was significantly higher in ovx compared
to sham and ovx IID groups. Percent trabecular bone was significantly higher in sham and
ovx lID versus ovx and ovx LD animals. and in ovx lID versus sham animals. Number of
trabecular osteoblastslmm and number oftrabecular osteoclastslmm were significantly
higher in ovx versus sham rats and significantly lower in. ovx LD and ovx HD versus ovx
rats. Serum IGF-I was significantly higher in ovx and significantly lower in ovx HD
compared to sham animals. The authors concluded that the increased trabecular
osteoblasts and osteoclasts induced by ovariectomy and prevented by estrogen
replacement was paralleled by similar increases in IGF-I also prevented by estrogen
replacement. They further concluded that this implied that IGF-I may be involved in the
pathogenesis ofovarian hormone deficiency-induced increased bone turnover (Kalu et al.
1994).





standard diet containing 1.2% calcium and 0.9% phosphorous. Animals were randomized
into five groups: contro~ ovx plus solvent vehicle (ovx), ovx plus 0.05 mg/kg IGF-I, ovx
plus 0.2 mglkg IGF-I, and ovx plus 0.8 mglkg IGF-I. Surgery was performed at 6 months
ofage, and IGF-I treatment began 8 weeks post-surgery and ended 11 weeks post-
surgery. Bones were labeled on the day prior to initiation of treatment (-1) with calcein
and on days 10 and 17 of treatment with demeclocycline by intraperitoneal injection. From
days 10 to 17, the 0.2 dose group exhibited significantly greater tibiallongitudinaJ growth
than ovx animals. From days -1 to 10, 10 to 17, and -1 to 17, the 0.8 dose group
exhibited significantly greater longitudinal tibial growth compared. to ovx animals. In
addition, the 0.8 dose group exhibited significantly greater longitudinal tibial growth from
days 10 to 17 and -1 to 17 than control rats. The 0.2 dose group had significantly greater
femoral trabecular calcium, hydroxyproline, and trabecular bone volume compared to ovx
animals. The 0.8 dose group had significantly greater trabecular bone volume compared
to ovx animals. All doses ofIGF-I increased the mineral apposition rate. Osteoclast
number and surface was increased in the 0.8 dose group. The authors concluded that
IGF-I treatment had beneficial dose-dependent effects on trabecular bone mass (Mueller et
aL 1994).
In a study of245 healthy community-dwelling Belgian women 70 years of age and
older, researchers assessed the relationship between serum IGF-I as determined by
radioimmunoassay and BMD of the hip as measured by DXA scan. Mean calcium intake
as measured by food frequency questionnaire was 813.8 mglday and was not related to




correlate with IGF-I. HMO ofthe femoral neck, Ward's triangle, and the trochanter major
was positively correlated to serum IGF-L Wrth multivariate analysis, IGF-I was also an
independent predictor of811O at femoral neck, Ward's triangle and the trochanter major.
The authors concluded that the findings suggested long-term. presence of IGF-I was
important in femoral integrity and that changes in the IGF regulatory system over time
may be involved in age-related osteoporosis (Hoonen et al. 1996).
Alkaline phosphatase and bone alkaline phosphatase. AJ.k.aline phosphatase
(ALP) is found in almost every tissue of the body. Major sources oftotal serum ALP are
liver and bone. Total serum ALP may be elevated during periods ofactive bone growth,
in liver disease, and in bone disease. Total serum ALP is considered an indicator of bone
formation. The major source of bone ALP is osteoblasts. Bone ALP is an isoenzyme
present on osteoblastic membranes, and synthesis increases during osteoblastic
differentiation Serum bone ALP is considered to be a specific indicator of bone
formation, and has been shown to correlate with histomorphometric and 47Ca bone
formation measurements (Seibel et al. 1992, Bettica and Moro 1995). Elevated total ALP
has been demonstrated in rats (Dick et al 1996, Sims et al. 1996) and humans (Diamond
et al. 1989, Duquenne et al. 1996) exhibiting greater than normal bone metabolism.
Urinary cross/inks ofcollagen. As previously discussed, collagen is the
connective tissue foundation of bone and is composed of chains ofamino acids cross-
linked together. Degradation products, hydroxyproline (OH-Pr) and deoxypyridinoline
(DPD) crosslinks, are produced with collagen lysis and are excreted into the urine.






considered to be a marker ofconnective tissue degradation and ofbone resorption. DPD
is present mainly in bone. DPD crosslinks are released only during bone resorption and so
are considered to be a specific marker for bone collagen degradation and to more
specifically reflect bone resorption (Seibel et aL 1992, Bettica and Moro 1995). Elevated
urinary OH-Pr and DPD crosslinks have been demonstrated in rats (Sims et al. 1996,
Goulding et a1. 1996) and humans (Diamond et al. 1989, Conte et al. 1989) exhIbiting
evidence ofgreater than normal bone metabolism.
Urinary mineral content. Calci~ magnesium, and phosphorous are
macronutrient minerals required in the human diet. These minerals are located primarily in
and are the major minerals ofbone. Serum calcium content is tightly regulated as only a
very narrow range ofvalues is tolerable to the human body. Calcium released from bone
and not used in one ofits other biological capacities is secreted via the urine. Because
calcium, phosphorous, and magnesium are involved in bone metabolism in concert with
each other, bone release ofcalcium is accompanied by bone release ofphosphorous and
magnesium (Anderson 1991, Wester 1987). Elevated urinary excretion ofcalcium,
phosphorous and magnesium. are considered markers of bone demineralization. Increased
urinary excretion ofcalcium has been demonstrated in rats (Goulding et a1. 1996, Dick et
aL 1996, Campos et at 1998) experiencing greater than normal bone metabolism.
MEASUREMENTS OF BONE PARAMETERS
Bone mineral density and bone mineral content. Archimedes' Principle. The
Archimedean Principle states a solid body immersed in liquid apparently loses as much of





a true unknown density based on liquid displacement. The density ofa solid body such as
a rat bone can be determined by immersion in a liquid of known density at a known
temperature. Air weight ofthe bone is detennined first followed by underwater weight.
True or displacement density is calculated from the two weights and the density of the test
liquid. In a study of five- and six-month-old retired female breeder rats whole and
hollowed femora, density was determined by both Archimedes' principle and Hologic
QDR-2000 DXA. Animals from a low-vitamin D Holtzman and a supplemental-vitamin D
SD colony were used to ensure detectable treatment differences. Whole femur densities
were significantly higher in the SD rats compared to the Holtmum rats as measured by
both Archimedes' principle and by DXA. Whole femur density values were greater as
measured by Archimedes' principle than by DXA However, whole femur densities
determined by the two methods were highly correlated (r = 0.82). Hollow femur densities
were greater than whole femur densities as measured by Archimedes' principle but lower
as measured by DXA. Femur ash weights and calcium content were highly correlated with
whole bone densities as measured by both Archimedes' principle and DXA. The authors
concluded that density determination is more relevant in whole than hollow bones, and
both Archimedes' principle and DXA were accurate in detecting differences between the
Holtzman and SD rats whole femora (Keenan et al. 1997).
Ashing. Bone mineral content may be determined by a combination ofwet and dry
ashing with reading of samples by atomic absorption spectrometry. Hill et al. (1986)
describe a wet and dry ashing procedure in which dry ashing in a muffle furnace at 375 0 C





heart, muscle, kidney, and serum which had been endogenously labeled with 6jZn, 54Mn,
59pe, and 51Cr were placed in borosilicate tubes. Also, one gram samples ofhomogenized,
freeze-dried wheat flour and rice flour containing known added levels ofC~ Mn, Fe, Zn.
and Ca as well as bovine liver and citrus leaves containing U.S. National Bureau of
Standards (NBS) certified levels ofC~Mn, Fe,~ Mg, Ca, and Cr were placed in
borosilicate tubes. Tubes were placed in the furnace, and the majority of sample organic
material including the lipid component was burned off. Sample ash was then suspended in
deionized water and nitric acid. Tubes were then placed in a heating block with addition
of hydrogen peroxide until digestion was complete. Samples were analyzed by flame
atomic absorption spectrometry. Percent recovery of65Zo. 54Mn, 59pe, and SICr from liver.
heart, muscle, kidney, and serum was not below 94 percent as the mean oftriplicate
analysis. Percent recovery ofadded C~ Mn, Fe, Zn, and Ca from wheat and rice flour
was not below 98 percent. Analysis was within the certified range 0 f both bovine liver and
citrus leaves. The authors concluded acceptable reproducibility was achieved for aU
analyses and a modification of this procedure may be applicable to other elements.
Dual energy x-ray absorptiometry (DXA). Bone mineral density and content may
also be determined by dual energy x-ray absorptiometry (DXA). DXA scanners directly
measure body components by passing two beam energies through the measured body.
Readings are generated based on the mass and type oftissue measured. In a study of
seven Ellegaard research pigs weighing 35 to 95 kg and representing a range of human
body weights and fatness, animals were fasted for 24 hours prior to scan. Pigs were
anesthetized with pentobarbital 15 to 25 mLJkg body weight and scanned twice with a
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total-body DXA scanner without repositioning. Animals were killed by intravenous
overdose ofpentobarbital after scanning and carcasses frozen at _20 0 C for two days.
Carcasses were then ground. and random samples of approximately 500 g were taken.
Percent body fat was detennined by ether/petroleum ether extraction from one sample.
Ash weight was determined from a separate sample. In a human segment of the study, six
Danish women (age 24 to 49 years and body mass index 19.3 to 23.5) were scanned with
the same DXA before and after having 8.8 kg ofporcine lard placed on their abdomens.
The scans were performed consecutively on the same day. Fat content of the porcine lard
was determined by ether/petroleum ether extraction. In addition, two other Danish
women and four Danish men (age 23 to 65 years and body mass index 19.2 to 29.7) were
scanned twice with repositioning to evaluate within day precision. In the pigs, percent
filt, fat mass ofsoft tissue, lean mass ofsoft: tissue, total-body bone mineral, and total-
body bone mineral density as measured by DXA did not differ significantly from values
obtained from chemical fat extraction and ash weights. Measurements in the humans of
simulated changes in fat mass of soft tissue and lean mass ofsoft tissue did not differ
significantly from expected values. DXA within-day precision was acceptable. However,
total-body bone mineral measurement did increase with placement of porcine lard. The
authors concluded that DXA is both accurate and precise in measuring soft tissue body
composition in longitudinal and cross sectional studies. They also concluded longitudinal
total-body bone mineral measurements may be difficult to interpret if large changes in soft:-
tissue occurred (Svendsen et al. 1993).













fed 100g guar gum diet supplementlkg diet meeting AIN-93 standards for eight weeks.
Rats were then anesthetized with 0.01 g xylazine fL and 0.95 g ketamine hydrochloridelL
at a dose of0.1 mlJlOOg body weight for lean rats and 0.12 to 0.15 mL/IOOg body
weight for obese rats. Animals were scanned with a Hologic DXA scanner~ killed by CO2
overdose, degutted, and frozen at -20°C. In addition, one rat was scanned four times in
one day, and five rats were scanned on three consecutive days. Carcasses were
autoclaved, individually blended, and samples collected in triplicate for ash determination
and chlorofonn-methanol fat extraction. Coefficient ofvariation for percent bone mineral
content of the single rat repeatedly scanned was 11.0. Coefficient ofvariation for percent
bone mineral content of the five rats scanned on three consecutive days ranged from 1.2 to
11.5. DXApercent fat, percent protein, and percent bone mineral content were highly
correlated with carcass chemical analysis ( r = 0.99, 0.96, and 0.81, respectively). The
authors concluded that DXA can be used to predict chemical analysis values. They also
concluded that because DXA detects body composition changes due to dietary treatment
it may be useful in assessing rats in intervention studies (Rose et aI. 1998).
In a study ofmale and female Wistar and GK (a genetic model ofnoninsulin-
dependent diabetes mellitus) rats age two to 24 months, animals were ad libitum fed
pelleted food. Twenty-one rats weighing 130 to 468 g were scanned in triplicate with a
Hologic QDR 4500 DXA scanner with repositioning on seven occasions over several
months to evaluate reproducibility and short-term variability. Long-tenn reproducibility
was also assessed. Twenty-six rats weighing 130 to 492 g were scanned in triplicate in one


















intraperitoneal injection ofsodium. pentobarbit~ and frozen at -30°C. One rat weighing
426g was intraperitoneally injected with a 9% saline solution in amounts from five to 40
mL with a scan after each injection. Carcasses were homogenized and total lipid content
determined by chloroform/methanol extraction. Short-term precision coefficient of
variation for bone mass content was 1.7%. Long-term precision coefficient of variation
for bone mass content was 0.7 ± 0.3%. Chemical analyses did not correlate well with
DXA measurements. DXA measurements of bone mass content, fat mass, lean mass, and
body weight were not significantly affected by saline injection. In rats weighing more than
200 g, it was demonstrated that single DXA scanning of body composition agreed with
triplicate scanning. The authors concluded that DXA scans demonstrated reliable,
accurate, and noninvasive measurements ofrat body composition (Bertin et aI. 1998).
Bone strength. Bone strength has been determined using a torsional device
(Burstein and Frankel 1971), four-point bending or three-point bending method (Turner
and Burr 1993). The three-point bending method is preferred for small bones such as rat
femora In this method, the femur is placed on two fulcra and force is delivered to the
midshaft by a crosshead moving at a constant speed. Initially. the bone yields to force
without sustaining damage. After the yield point, microfractures occur with continued
force. Maximum strength of the bone is represented by the maximal amount of force
applied to the bone at fracture (Turner and Burr 1993, Kiebzak et aI. 1988).
In the Kiebzak et aI. (1988) study, six-, 12- and 24-month-old male Wistar rats
were fed ad libitum National Institutes ofHealth open formula rat chow containing 1.2%





a computerized lnstron Universal Testing Machine on right femora. Femurs were
positioned with one fulcrumjust distal to the lesser trochanter and the other proximal to
the medial and lateral condyles. Distance between the fulcra was 2.4 em. Breaking force
was applied at a crosshead speed of 5.0 mm/minute at the bone midshaft perpendicularly
to the long axis of the bone. Bones were from anterior to posterior plane. Yield force
was significantly lower in 24-month-old compared to six- and 12-month-old rats. Yield
stress, yield deformation, and yield strain was significantly lower in 24-month-old
compared to six- and 12-month-old rats and in six- compared to 12-month-old rats.
Ultimate deformation was significantly lower compared to six-month-old rats and higher
compared to 24-month-old rats in 12-month-old rats. The authors concluded that
significant age-dependent changes in bone strength were seen as measured by the three-
point bending method.
APPROPRIATENESS OF THE RAT MODEL
In general, the rat animal model has several practical advantages. Rats are less
costly to house and care for than larger laboratory animals. The short rat life span aids in
studying effects of aging. Mineral metabolism has been extensively studied in the rat and
much information is available. Nutritional requirements of the rat have been defined and
standard diet components are available. While the rat model is usefu~ its limitations must
be considered. Rats lack Haversian systems and continue to gain bone mass throughout
the life span. Body weight may not be an indicator ofage. Longitudinal studies may not





The rat model's usefulness specifically for bone research should also be
considered. Dick et at (1996) determined that rats ovariectomized at six. months ofage
and fed a 0.1 % calcium diet displayed many similarities to postmenopausal women in
calcium and phosphorous homeostasis. Bagi et al (1996) determined responses in
proximal femora ofovariectomized rats were similar to responses noted in proximal
femora of postmenopausal women. In 1997, Bagi et al. concluded that the femoral neck
was the optimal site for mechanical testing or bone histomorphometry when using the
ovariectomized rat model in osteoporosis research because of the clinical significance of
the proximal femur in osteoporosis in humans. The authors concluded that the rat
proximal femur parallels the hwnan proximal femur in BMD, mass, structure and strength.
In a study of40 female Fischer-344 rats, animals were ad libitum fed a commercial
rat diet containing 0.90.10 calcium, 0.75% phosphorous, and 600 ill/kg vitamin D) and
given free access to tap water. Rats were killed at three, six. nine, and 12 months of age.
Each rat was irUected with oxytetracycline 24 days prior to kill, xylenol orange 19 days
prior to kill, demeclocycline 14 days prior to kill, alizarin complexone nine days prior to
kill., and calcein four days prior to kill. Longitudinal bone growth in the proximal tib~
caudal vertebra and cranial vertebra as measured by demeclocycline and calcein markers
declined dramatically from three to six, nine, and 12 months. In the first lumbar vertebral
body, cancellous bone remodeling increased from approximately 70% of all fonnation sites
in three-month-oW rats to approximately 85% in six-month-old rats and 91% in 12-month-
old rats. In the proximal tibial metaphysis, modeling sites decreased from approximately






rats and 16% in 12-month-old-rats. Proximal tibial metaphysis remodeling sites increased
from approximately 21% of all formation sites in three-month-old rats to approximately
30% in six-month-old rats and 66% in 12-month-old rats. The author concluded that
these findings suggested that remodeling was the prevailing activity in vertebral and tibial
cancellous bone in aged rats. He also concluded that this activity was similar to higher
mammals (Erben 1996). The rat model ofosteoporosis has been determined to be useful





Experimental Design. Eighty-four weanling (21 days ofage) female Sprague-
Dawley rats were obtained from SASCO (Kingston, NJ). This experiment was the second
part ofa larger two-phase study. Animals were maintained on rat chow and deionized
water for three days after arrival. After acclimation, animals were randomized into two
ovarian honnone status groups (OHS) (sham-operated or ovariectomized) and four iron
modified dietary regimens (calculated to be 6 ppm, 12 ppm, 35 ppm or 150 ppm as iron
citrate). Animals were maintained on diets for 15 weeks, and 12 weeks following surgical
treatment. The life span period of interest was from 17 weeks of age (skeletal maturity) to
29 weeks ofage for both intact and induced ovarian hormone deficient animals, simulating
life span iron effects on adult and postmenopausal bone metabolism.
Housing. Animals were maintained under a 12 hour light/dark cycle and in
temperature-controlled conditions at the Oklahoma State University Laboratory Animal
Resources (LAR) facility under the supervision of a veterinarian. The rats were housed in
individual plastic cages with raised plastic floor grids. Small amounts of ground corn husk
bedding was below the grids for waste absorption. Cages, feed dishes and water bottles
were changed weekly.
Diet. Diet components were purchased from Teklad (Madison, WI). Diet was
prepared by researchers according to AIN-93 G and AIN-93 M standards (Reeves et al.
1993) with the exception of iron concentration (Tables 1-3). Four dietary iron
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concentrations were prepared: two insufficient (6 and 12 ppm), one recommended control
(35 ppm) and one excess (150 ppm). Mineral mixes and diets were prepared lowest to
highest iron concentration and growth before maintenance to avoid carryover
contamination. Mineral mixes were mixed in a washed and deionized water rinsed ceramic
jar containing washed and deionized water rinsed ceramic balls. Diet components were
mixed with a Hobart stand mixer in an acid washed plastic mixer bowl (Hobart
Manufacturing Company, Troy, OR). All diets were labeled appropriately with
fonnulation and dietary iron concentration. All diets were stored refrigerated.
Feeding. Each rat was allocated two plastic cups labeled with rat number, diet,
and treatment. Feed was weighed into the cups twice a week:, and cups taken to the LAR
and stored refrigerated until feeding time. Biweekly feed amounts were based on animal
weight and remaining feed weight prior to surgery and additionally on surgical treatment
after surgery. Animals were fed daily in the late afternoon in glass crucible dishes with
stainless steel grate inserts and lids.
Water. Rats were provided ad libitum access to deionized water in glass bottles
with straight stainless steel sipper tubes. Fresh water was given three times per week.
Surgery. Rats were sham operated or ovariectomized at 17 weeks of age (skeletal
maturity) based upon DHS group randomization. Food was withheld for 12 hours and
water withheld for 6 hours prior to surgery. The procedures were perfonned at the
Oklahoma State University LAR facility by a veterinary surgeon. Animals were
anesthetized by halothane inhalation. Dorsal hair was shaved and underlying skin was









access to ovaries. Ovaries were removed by ligation in ovariectomized animals. Ovaries
were lifted from and then replaced in the body in sham operated animals. In all animals,
incisions were closed with liquid veterinary adhesive. Post procedure, animals were
observed until fully awake and alert. Water was given to each animal after alertness
returned. Feed was given to all animals at usual feeding time.
Necropsy. Necropsy was performed on 10 to 12 animals per day four days per
week for two consecutive weeks. Animals were moved from the LAR facility to the
Oklahoma State University Nutritional Sciences Laboratory (NSL) one day prior to
scheduled necropsy. Twelve hours prior to necropsy, the rats were transferred to
metabolic cages for urine and fecal collection. Feed was withheld but deionized water
given. Anesthesia was achieved by intraperitoneal injection with ketamine and xyJazine
with a dosage of50 and 10 mgIkg body weight, respectively. Animals were then weighed
and scanned by dual x-ray absorptiometer (DXA). Blood was collected from the
abdominal aorta, processed and stored appropriately. Bones (femurs, tibiae, spines. and
calveri) and organs (heart. kidneys. liver, spleen, uterus. and ovaries) were collected,
cleaned, weighed, and stored appropriately. Remainder of rat carcass was disposed of
properly.
Tissue collection and storage. Urine was collected prior to surgery and to
necropsy. centrifuged, alliquotted, and stored frozen at -200 C. Feces was collected after
two feedings labeled with Blue Dye #1 aluminum (Research Diets, Incorporated. New
Brunswick., NJ) prior to necropsy and stored frozen at -200 C. Whole blood collected at





tests was analyzed immediately. Other serum collected and plasma were processed and
stored frozen at -200 C. Femora and tibiae were trimmed ofmuscle and cartilage taking
care not to damage the periosteum. Right femur was processed first and stored frozen at
-800 C. Right tibia and left femur were stored frozen at -200 C. Left tibia was stored at
room temperature in 70% ethanol. Whole spines were stored frozen at -200 C, thawed
individually, cleaned and separated to obtain lumbar vertebrae 3, 4 and 5. L3, 4 and 5
were stored frozen at -200 C. Mineral free gloves were used at all times during bone
cleaning and bones were cleaned lowest to highest dietary iron concentration. Liver was
the first organ processed and two sections were stored frozen at -800 C. One section of
liver and the heart, kidneys and spleen were stored frozen at -200 C.
Analyses. Nutrition indicators. Body composition was measured immediately
prior to necropsy by whole body scan with a Hologic QDR 4500A Fan Bean X-ray Bone
Densitometer with appropriate software for small animals (Hologic. Inc., Waltham, MA).
Hematology testing was done on whole blood immediately following necropsy with a
Pentra 120 Retic (software version 3.13) and chemical solutions as appropriate for each
analysis (ABX Hematology, Inc., Irvine, CA).
Clinical chemistry testing was done on serum immediately following necropsy with
a COBAS Fara II (Roche Diagnostic Systems, Indianapolis, IN). Glucose testing was
performed using an enzymatic approach utilizing hexokinase coupled with glucose-6-
phosphate dehydrogenase as described by Neeley (1972) and appropriate Roche (Roche
Diagnostic Systems, Inc., Somerville, NJ) reagent. Serum urea nitrogen (SUN) was











totally enzymatic SUN measuring procedure. Aspartate aminotransferase (AST) was
performed with the appropriate Roche reagent based on a modification ofthe procedure
ofKarmen (1955). Alanine aminotransferase (ALT) was performed with the appropriate
Roche reagent based on a modification ofthe procedure of Wroblewski and LaDue
(1956). Alkaline phosphatase (ALn was performed with the appropriate Roche reagent
based on a modification of the reference method of the American Association for Clinical
Chemistry (Tietz 1983). Albumin was performed with the appropriate Roche reagent
based on a modification of the bromocresol green binding assay (Doumas et aI. 1971).
Bone status indicators. IGF-I testing was performed on serum stored frozen at
-20 0 C and thawed immediately prior to assay. A Nichols Institute Diagnostics (San Juan
Capistrano, CA) IGF-I by extraction kit was used with modified fonnic acid rat extraction
method (Kalu 1994). Tube counts were performed using a Cobra II Auto-Gamma
(Packard Instrument Co., Downers Grove. IL).
Alkaline phosphatase extracted from bone was perfonned with fractured third
lumbar vertebrae (L3) utilizing a modification ofthe method of Farley et al. (1992). Each
bone was placed in a glass test tube containing 3.0 mL ofphosphate buffered saline with
0.02% sodium azide and incubated overnight (approximately 12 hours) at 4 0 C. After
density by displacement, the bone was crushed and was then transferred to another tube
containing 3.0 mL of 0.01% Triton-XI 00 with 0.02% sodium azide for 72 hour extraction
at 4°C. Bones were centrifuged for 15 minutes at 1500 xg. The extract was decanted and
analyzed by Cobas FARA II clinical analyzer with a Roche ALP reagent.






with urine stored frozen at -20 0 C and thawed immediately prior to testing. A COBAS
Fara II with appropriate Roche reagent for each analysis was used. The Roche reagent for
urinary creatinine content is based on a kinetic modification ofthe Jaffe reaction (Jaffe
1886, Larson 1972). The Roche reagent for urinary calcium content is based on Arsenazo
ill, a very sensitive and specific reagent which requires slightly acidic conditions
(Michaylova and IllkovaI971). The Roche reagent for urinary magnesium content utilizes
chlorophosphonazo ill (Ferguson et aL 1964), a sensitive dye for magnesium and calcium
determination at neutral pH, modified to prevent calcium interference. The Roche reagent
for urinary inorganic phosphorous content is based on a modification of Daly and
Ertingshausen's (1972) procedure.
Urinary DPD was performed on urine stored frozen at -20 0 C and thawed
immediately prior to testing. A Pyrilinks-D kit (Metra Biosystems, Inc., Mountain View,
CA) was used. The Pyrilinks-O reagent is based on a monoclonal antibody which is
specific for DPD (Robins et al. 1994). Due to hyperconcentration, samples were diluted
once based on urinary creatinine and a second time by combining 50 I-tL ofthe previously
described dilution with 500 .uL ofassay buffer (personal communication from Brenda













Table 4 Urinary sample dilution for DPD analysis in female SD rats
UriBary
First CreatiJllae Deionized
DUutioa (mgldL) Sample Water
A <30 0_05 ml 0.2 ml
B 30-75 0.05 ml 1ml
C 75-150 0.05 ml 2.5 m1
D >150 0.05 m1 4.5 m1
Plate washing was perfonned by E~ 405 Auto Plate Washer (Bio-Tek Instruments,
Inc., Winooski, VT) and plate counting by Elx 8081 Ultra Microplate Reader (Bio-Tek
Instruments, Inc., Wmooski, Vl).
Urinary hydroxyproline was determined using samples collected prior to surgery
and necropsy and stored frozen at -20 0 C until analysis. The method of Bergman and
Loxley (1970) was utilized. A Tecator 1024 Shaking Water Bath (Sweden) and Beckman
D~ 640 Spectrophotometer (Beckman Instruments, Inc., Fullerton, CA) set at 562 nm
were used.
Fracture force were measured on femurs stored frozen at -20 0 C until testing.
Bones were thawed overnight and soaked in 0.9% saline for 24 hours. Bone length was
measured to the nearest millimeter, and bones were fractured with an Instron Universal
Testing Machine Model TM-S (Instron Corporation, Canton, MA) with a crosshead speed
of 1.0 mm/minute according to the method ofKiebzak et al (1988). Marrow was















Bone mineral density and bone mineral content were measured in the intact rat
immediately prior to necropsy by whole body scan with a Hologic QDR 4500A Fan Bean
X-ray Bone Densitometer (Svendsen et at 1993, Bertin et at 1998, Rose et at 1998) with
appropriate software for small animals (Hologic, Inc., Wahham, MA). Rats were scanned
positioned straight and flat on ventral surfuce, limbs spread, tail lying to the side. Scan
was initiated in the center position and lasted approximately two minutes.
Bone mineral density of the left femur was also detennined by Archimedes'
principle (Keenan et aL 1997). Underwater and air weighing were perfonned with a top
loading Mettler H18 balance and Density Determination Kit .ME-33340 (Mettler
Instrument Corporation, Princeton, NJ). Bone density was then calculated by using the
fonnula P2 = AlP x Po where P2 = density of the femur, A = weight of the femur in the air,
P = buoyancy of solid body in type I water, and Po =density of type Jwater at a given
temperature.
Bone mineral content was also determined by wet and dry ashed using a
modification ofthe method ofHill et aI. (1986) using mineral free gloves. Wet ashing was
performed under an acid hood. Acid washed tubes were double labeled with a high
temperature pencil when hot. After being allowed to coo~ tubes were weighed empty,
and re-weighed after sample placement. Bones were dried at 100°C for 24 hours.
Weighed tubes were placed in an lsotemp Dry Bath 145 heating block (Fisher Scientific,
Pittsburgh, PA). Fifty ilL each oftype I deionized water, Ultrex hydrogen peroxide







sample tube using a clean and separate mineral free pipette tip for each solution and a
pipette not having a metal mechanism. Heating block was turned on and set at 80 ° C.
After 15 minutes, temperature was raised to 90° C. After 15 minutes, 100 ~L ofH20 2
was added to each tube, and heating block temperature was raised to 100° C. After 30
minutes, 100 ,uL ofH20 2 was added to each tube, and heating block temperature was
raised to 105° C. Hydrogen peroxide (100 ,uL) was added three more times after 15 or
30 minute waiting periods before being allowed to evaporate to dryness.
Tubes were then placed in an acid washed beaker with open ends of the tubes
facing the bottom of the beaker and an acid washed petri dish placed on the beaker to
close off air. The beaker of tubes was placed inside a Lindberg 847 ashing oven (General
Signal, Watertown. WI). Samples were processed for 2880 minutes at 375 0 C and then
held for 25 minutes at 100° C.
Wet and dry ashing procedures were alternately repeated until all samples turned
white and bone was not recognizable. Ashed samples will be analyzed for minerals at a
later date with a Perkin Elmer 5100 PC flame atomic absorption spectrometer (Perkin
Elmer Corporation, Norwalk, Cn.
Animals were injected intraperitoneally at 8 days and 24 hours prior to necropsy
with calcein at a dosage ofO,75mg/100 grams body weight. Bone appositional growth
rate and histology will be detennined at a later date.
Statistics. Data were analyzed by PC SAS version 7.0 (SAS Institute, Cary, NC)
and significance was set at P <0.05. Means ofvariables ofnecropsy animals in experiment











rrable 1 American Institute of Nutrition 1993 Purified Diet Components for Laboratory Rodents
ln2redient IGrowth Maintenance
K:ornstarch f397.49 g 465.69 g
tasein ~OO.O g 140.0 g
Dextrose 132.0 g 155.0 g
Sucrose see Table 2 ~Table3
Soybean oil 70.0 g ~O.O g
Celufil fiber 50.0 g 50.0 g
Mineral mix 35.0 g 35.0 g
Vitamin mix 10.0 g 10.0 g
L-Cystine 3.0 g 1.8 g
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rrable 2 American Institute of Nutrition 1993 Growth Mineral Mix
~n2redient 16 ppm 12 ppm 135 ppm 150 ppm
~alcium carbonate ~0.04% Ca 357 357 357 357
Potassium phosphate monobasic (22.76 P, 28. 73% K 196 196 196 196
Potassium citrate, Tri-K monohydrate 136.16% K 70.78 70.78 70.78 70.78
Sodium chloride 139.34% Na, 60.66% Cl 73.275 73.275 73.275 73.275
Potassium sulfate 144.87% K, 18.39% S 46.6 46.6 46.6 46.6
Maimesium oxide kiO.32%Mg 24 24 24 24
Ferric citrate 16.5% Fe (35 ppm) 0.88 1.86555 5.8883 25.8126
~inc carbonate 52.14% Zn 1.65 1.65 1.65 1.65
Manganous carbonate 147.79%Mn 0.63 0.63 0.63 0.63
Cupric carbonate 57.47% Cu 0.3 0.3 0.3 0.3
Potassium iodate ~9.3% I 0.01 0.01 0.01 0.01
Sodium senenate, anhydrous ~1.790,/0 Se 0.01025 0.01025 0.01025 0.01025
A nium paramolybdate, 4 hydrate 54.34% Mo 0.00795 0.00795 0.00795 0.00795
Sodium meta-silicate, 9 hydrate 9.88% Si 1.45 1.45 1.45 1.45
Chromium potassium sulfate, 12 hydrate 10.42% Cr 0.275 0.275 0.275 0.275
Lithium chloride 16.38% Li 0.0175 0.0175 0.0175 0.0175
aoric acid 17.5%B 0.0815 0.0815 0.0815 0.0815
Sodium fluoride 45.24%F 0.0635 0.0635 0.0635 0.0635
Nickel carbonate 45%Ni 0.0318 0.0318 0.0318 0.0318
A nium vanadate 43.55% V 0.0066 0.0066 0.0066 0.0066
Total mineral elements 773.069 774.0546 778.0773 798.4516
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ifable 3 American Institute oCNutrition 1993 Maintenance Mineral Mix
~n2redieDt ~ppm 12 ppm ~5ppm 150 ppm
iCalcium carbonate 40.04% Ca 357 357 357 357
Potassium phosphate monobasic 22.76 P, 28.73% K 250 250 250 250
Potassium citrate, Tri-K monohydrate 36.16% K 28 28 28 28
Sodium chloride 39.34% Na, 60.66% CI 73.275 73.275 73.275 73.275
Potassium sulfate 44.87% K, 18.39% S 46.6 46.6 46.6 46.6
Magnesium oxide 60.32% Mg 24 24 24 24
Ferric citrate 16.5% Fe (35 ppm) 0.88 1.8655 5.8883 25.8126
linc carbonate 52.14% Zn 1.65 1.65 1.65 1.65
;Manganous carbonate ~7.79%Mn 0.63 0.63 0.63 0.63
Cupric carbonate 57.47% Cu 0.3 0.3 0.3 0.3
Potassium iodate 59.3% I 0.01 0.01 0.01 0.01
Sodium senenate, anhydrous 41.790.10 Se 0.01025 0.01025 0.01025 0.01025
Ammonium paramolvbdate, 4 hydrate 54.34%Mo 0.00795 0.00795 0.00795 0.00795
Sodium meta-silicate, 9 hydrate 9.88% Si 1.45 1.45 1.45 1.45
Chromium potassium sulfate, 12 hydrate 10.42% Cr 0.275 0.275 0.275 0.275
Lithium chloride 16.38% Li 0.0174 0.0174 0.0174 0.0174
Boric acid 17.5% B 0.0815 0.0815 0.0815 0.0815
Sodium fluoride 45.24%F 0.0635 0.0635 0.0635 0.0635
Nickel carbonate 45%Ni 0.0318 0.0318 0.0318 0.0318
A nium vanadate 43.55% V 0.0066 0.0066 0.0066 0.0066
TotaI mineral elements 784.289 785.2745 789.2973 809.2216
Sucrose 206.145 205.1595 201.1367 181.2124
VI
VI
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Eighty-four weanling Sprague-Dawley rats were randomized to dietary Fe (6, 12,
35 and 150 ppm) and to ovarian hormone status (ovariectomized or sham-operated)
groups three days after receipt. Four animals were dropped from all analyses due to
illness during the experiment. Animals were fed Fe modified AIN-93 G for seven weeks
and Fe modified AIN-93 M thereafter; both formulations were adjusted for the four Fe
levels. Pre-surgery, animals were pair fed to the diet group weighing the least. Following
surgery, animals were pair fed to the 150 ppm sham group but where necessary were fed
less to match for weight. Animals were fed for 15 weeks then ovariectomized or sham-
operated under halothane anesthesia. Twelve weeks post-surgery, animals were fasted for
12 hours in plastic metabolic cages for urine and fecal collections. Animals were then
anesthetized with ketamine/xylazine, DXA scanned and exsanguinated by abdominal aorta
puncture. Tissues were perfused with cold saline (9 gIL) prior to collection. No diet or
ovarian hormone status (ORS) effects were observed for bone strength as measured by
three-point bending. Diet x ORS interactions occurred for femur area and length and for
change in femur area and length. Ovarian hormone status effect was seen for femoral
bone mineral density (BMD) and displacement density ofL3 vertebra. Diet effects were
noted for change in femoral HMD, cortical area, bone mineral content (BMC), and
alkaline phosphatase (ALP) extracted from L3. Diet and OHS effects were seen in L3
true density change, hemoglobin (Hb) concentration and insulin-like growth factor-I (IGF-
I). Final body weight was significantly greater in the ovx versus sham rats regardless of










deoxypyridinoline crosslinks excretion pre-surgery. Diet x OHS interaction was seen for
final urinary calcium excretion. Ovarian honnone status effect was observed for final
urinary deoxypyridinoline (DPD) crosslinks, hydroxyproline excretion, change from
surgery to final urinary hydroxyproline and DPD crosslinks excretion. As expected, DRS
affected bone. Dietary iron intake also affected bone. Dietary iron played a role in bone





























In the United States alone, a conservative estimate is that nearly half ofall women
over the age of 50 will suffer a fracture related to osteoporosis, resulting in more than 1.5
million fractures per year including painful and often debilitating hip fractures (32). Other
cormnon osteoporotic fracture sites include the vertebrae and distal foreann (10).
Osteoporosis affects twice as many women as men, and is especially prevalent in
post-menopausal women. Both natural and surgical menopause are associated with an
initial phase ofrapid bone loss which may last seven to ten years (8).
It has been estimated that only 50% of individuals regain mobility within one year
of hip fracture (20) and reported that within one year ofhip fracture 21.5% ofmen and
35.4% ofwomen followed were deceased (30). Medical costs associated with
osteoporotic fractmes in1995 have been estimated at $13.8 billion (23).
Although there are numerous ahernatives available in the fight against
osteoporosis, none can completely prevent bone loss. Hence, it is important to investigate
other :factors which may prevent bone loss.
Iron is integral in the hydroxylation of collagen matrix, the connective tissue
foundation ofbone (24). As iron is key in this reaction, both inadequate and excessive
iron intake may affect connective tissue metabolism.. Yet, the association between dietary
iron intake and bone metabolism is unclear. While inadequate iron intake is found across
racial, gender, and socioeconomic boundaries worldwide (11), excess iron intake is
increasing due to the availability ofiron supplements and food fortification policies (25).























the purpose ofthis study was to investigate the effects ofdietary iron in ovarian hormone
sufficient and deficient skeletally mature rats and to determine ifthere were differences
between iron and/or ovarian. hormone status (OHS) groups in bone density and mineral
content as well as in blood and urine indicators ofbone metabolism.
MATERIALS AND METHODS
Experimental design. This study was a completely randomized 2 x 4 factorial
block design. Independent variables were dietary iron levels and ovarian honnone status.
This experiment was the second part ofa larger two-phase study.
Animals. Eighty-four weanling female Sprague-Dawley (SD) rats (SASCO,
Kingston, NJ) were acclimated on standard rat chow and deionized water for 3 days after
arrival prior to randomization Animals were maintained on dietary treatment for 15
weeks before surgery.
Diets. Diets were calculated to contain 6, 12,35 or 150 ppm iron as iron citrate.
All other minerals met the AIN-93 recommendations (28). Animals were fed AlN-93 G
for seven weeks and then switched to the respective mineral concentration AIN-93 M
diets for the remainder ofthe experiment. Animals were pair fed to the 150 ppm sham
group but where necessary were fed less to match for weight.
Treatment. After 15 weeks of initial dietary treatment, animals were anesthetized
by halothane induction and operated. Ovaries were located through a single dorsal incision
and ligated in ovx animals or replaced in sham animals. Animals were IIlonitored post-
procedure until fully alert.

















with DI water for twelve hours in plastic metabolic cages for urine and fecal collections.
At the time ofsacrifice, animals were anesthetized with ketaminelxylazine and dual energy
x-ray absorptiometry (DXA) scans were performed. Animals were exsanguinated by
abdominal aorta puncture, and tissues were perfused with cold saline (9g/L) prior to
collection.
Analyses. Biochemical tests including albumin, glucose, serum urea nitrogen,
serum creatinine, alanine aminotransferase (ALT), aspartate aminotransferase (AST), and
alkaline phosphatase (ALP) were performed with a COBAS Fara II (Roche Diagnostic
Systems, Indianapolis, IN) and appropriate reagents. Hematological analyses were
performed with a Pentra 120 Retic (ABX Hematology, Inc., Irvine, CA). Body
composition was determined with a Hologic QDR 4500A DXA scanner.
Insulin-like growth fuctor I (IGF-I) was analyzed using a Nichols Institute
Diagnostics (San Juan Capistrano, CA) kit and modified fonnic acid rat extraction method
(16). Alkaline phosphatase in bone was measured using a modification ofthe method of
Farleyet a1 (13) by placing third lumbar vertebra (L3) into a glass test tube containing 3.0
mL ofphosphate buffered saline with 0.02% sodium azide. Vertebrae were incubated
approximately 12 hours at 4 0 C to remove contaminants. After density by displacement
determination, vertebrae were crushed and transferred into another tube containing 3.0 mL
of 0.01% Triton-XIOO in phosphate buffered solution with 0.02% sodium azide for 72
hour extraction at 4 0 C. Crushed vertebrae were centrifuged for 15 minutes at 1500 xJg
to remove insoluble materials. The extract was then decanted and processed with a Cobas















determined using the method ofBergman and Loxley (3). Urinary deoxypyridinoline
(DPD) crosslinks were determined using a Pyrilinks-D kit (Metra Biosystems, Inc.,
Mountain View, CAl. Double dilution was performed based on urinary creatinine content
due to hyperconcentration (personal communication, Brenda Smith, Ph.D.). Urinary
creatinine level and urinary excretion ofcalcium (Ca), magnesium (Mg), and phosphorous
(P) were analyzed with a COBAS Fara IT and appropriate Roche reagents for each
analysis.
Bone mineral content (BMC) and bone mineral density (BMD) were analyzed for
whole body and right femur by DXA (Hologic QDR 4500A Fan Beam X-ray Bone
Densitometer, Hologic, Inc., Wahham, MA) with appropriate software for small animals.
BMD ofthe right femur and L3 was also determined by Archimedes' principle (17),
weighing the sample using a Density Determination Kit ME-33340 (Mettler Instrument
Corporation, Princeton, NJ).
Femur fracture force was measured at the rate of Immlmin according to the
method ofKiebzak et aI. (18) using an Instron Universal Testing Machine Model TM-S
(lnstron Corporation, Canton, MA).
Data analysis. Means of variables of necropsy animals fed the same diets as those
in the second experiment were subtracted by diet group as measures of change due to
treatment. Data were analyzed by PC SAS version 7.0 (SAS Institute, Cary, NC), and
significance was set at P <0.05.
RESULTS

















density than the sham rats (Tables 5 and 6). Rats given the 6 ppm diet had greater change
from surgery to necropsy in femur BMD, BMC and cortical area than rats fed other diets
(Table 5). Animals fed the 6 ppm diet and sham animals regardless ofiron status had the
greatest change from surgery to necropsy in L3 true density (Table 6). No diet or OHS
effects were seen for bone strength as measured by thret?point bending (data not shown).
Diet x OHS interactions were seen in femur length and area and change in femur
length and area from surgery to necropsy with 6 ppm ovx animals having greater length
and change in length than all other groups, significantly more than 6 and 150 ppm sham
groups (Table 5).
Although mean weights of rats did not differ initially between diet and OHS
groups and despite pair feeding to the 150 ppm sham group following surgery, regardless
ofiron status the ovx rats weighed significantly more at necropsy than the sham rats
(Figure 1). Femur area was not correlated with body weight.
All of the ovariectomized rats regardless of iron status and animals fed the 6 ppm
diet had significantly higher concentrations ofIGF-I than did all other rats (Figures 2 and
3). Animals given the 6 ppm diet exhibited a significantly greater change from surgery to
necropsy in alkaline phosphatase extracted from the third lumbar vertebra (L3) than did
animals fed the 12 and 150 ppm diets (Table 6).
At pre-surgical urine collection, animals given the 6 ppm diet excreted more
urinary DPD crosslinks than animals given all other diets, significantly more than the
animals given the 35 and 150 ppm diets. The 6 ppm diet animals also excreted more















and 35 ppm diets (Table 7). The rats fed the 6 ppm diet excreted significantly more
urinary Ca and Mg than all other rats (Table 8).
Ovariectomized rats regardless of iron status excreted significantly more urinary
DPD crosslinks and hydroxyproline and had a significantly greater change in excretion
from pre-surgery to necropsy than the sham-operated rats (Table 7). A significant diet x
DRS interaction was seen for urinary Ca excretion with the 6 ppm sham and 6 ppm ovx
groups tending to excrete more urinary calcium than all other groups, significantly more
than the 12 ppm sham and 150 ppm sbam groups (Table 8).
An OHS effect occurred for albumin and ALT; however, mean values remained
within normal limits (data not shown). A diet x DRS interaction occurred in serum urea
nitrogen with the 150 ppm sham animals having significantly higher values than all other
animals except 12 ppm sham rats. A diet x ORS interaction was seen in serum glucose
with 6, 12, 35 and 150 ppm ovx rats having significantly higher values than their
respective sham groups (data not shown). Animals fed the 6 ppm diet exhibited iron
deficiency as evidenced by increased red blood cell (RBC) numbers, mean cell volume
(MCV) and reticulocyte (RETIC) numbers and decreased hemoglobin (Hb)
concentrations. Ovariectomized rats regardless of iron status exhibited greater Hb
concentrations than sham. animals although values remained within normal limits (Table 9).
DISCUSSION
The increased and greater change in femur area and length in the 6 ppm ovx
animals together with the lower femoral and L3 HMO in ovx animals suggests possible













supported by the animals fed the 6 ppm diet having greater change in femur BMD, BMC
and cortical area than animals fed other diets as well as by the rats given the 6 ppm diet
and sham rats regardless of iron status having the greatest change in L3 true density.
Significantly increased femur and tibial length in ovx compared to sham animals has been
previously reported (26, 27, 35). Increased bone formation and resorption with overall
net loss in ovx animals compared to sham animals has been previously reported in the rat
femur (1,2, 15, 19,26,27,29,31,33) and tibia (21,34,35). Increased femoral cortical
area has been demonstrated in ovx rats (15). Related to the development ofosteoporosis,
this suggests that low lifetime dietary iron intake may exacerbate hormone-induced bone
loss.
Despite pair feeding, ovx weighed significantly more at necropsy than sham
animals. This is similar to other research in which animals were pair fed or ad hbitum fed
(1,2, 7, 15, 19). Similar to other research, it appears no partial protection from
osteopenia was provided by greater weight (29, 35).
The significantly higher IGF-I in rats fed the 6 ppm diet and in the ovx rats
regardless of iron status suggests greater bone remodeling in these groups compared to
the other groups. This increased IGF-I in ovariectomized versus sham animals
corresponds with Kalu et al's (16) findings although their IGF-I values were higher than
ours. The increased level ofIGF-I is similar to other findings of increased bone regulatory
hormones ofserwn cortisol and parathyroid hormone in iron deficient rats (5). Increased
IGF-I in the ovx group corresponds with increased bone metabolism seen in ovx rats












rats supplemented with high doses ofIGF-I exlnbiting enhanced bone resorption (22). It
has also been found that serum IGF-I is an independent predictor of human female femoral
BMD and suggested that IGF-I plays a direct role in the endocrine regulation ofbone
remodeling (4).
Increased bone remodeling is also suggested in rats given the 6 ppm diet by the
greater change in alkaline phosphatase extracted from L3. This is similar to findings of
elevated ALP in ovariectomized versus sham animals at 9 days and 1, 3, and 6 weeks
post-surgery; 12 months post-surgery; and in cultured tibial su.rfuce cells in ovariectomized
versus sham animals at I and 6 months post-surgery (31, 12,6,21). However,
ovariectomized rats were found to show no difference in ALP compared to sham animals
at 3 months post-surgery (21).
Further evidence of increased bone metabolism. was seen in animals fed the 6 ppm
diet with the greater pre-surgical excretion ofurinary hydroxyproline and DPD crosslinks.
Increased bone metabolism was also evidenced by the ovx animals' greater excretion and
greater change in excretion ofurinary hydroxyproline and DPD crosslinks. Studies have
shown increased urinary excretion one or both ofthese bone resorption markers in ovx
versus sham animals (31, 14, 6), and prevention of this increase in ovx animals with
estrogen replacement (14). Iron overload but not deficiency been associated with elevated
bone resorption markers in a study of men with PH who exhibited elevated urinary
hydroxyproline compared to control men (9). A paucity of information exists on bone
metabolism and iron in human females.








contained in bone and the narrow tolerable serum range ofcalcium, the increased urinary
calcium and magnesiwn excretion in rats fed the 6 ppm diet at surgery suggests greater
bone resorption than bone formation in this group. Animals fed the 12 ppm diet also
showed greater resorption than formation indicating increased resorption in both low iron
groups. It has been demonstrated elsewhere that iron deficient rats excreted significantly
more urinary calcium than control rats (5).
The increased urinary calcium excretion ofthe 6 ppm sham and 6 ppm ovx groups
at final urine collection wouJd also suggest greater bone resorption than bone formation.
Others have reported greater Ca excretion following ovariectomy in rats (6, 12, 14,26).
The diet x OHS interaction for serum urea nitrogen with the greatest value in the
150 ppm sham group indicates generalized tissue degradation in this group. This is
supported by their significantly lower final body weight. This group also had lower food
intake than all other groups (data not shown).
Our findings indicate significantly different blood and urinary indicators ofbone
metabolism based on both surgical and dietary treatment. Diet effects were seen in Hb;
IGF-I; pre-surgical urinary DPD, hydroxyproline, calcium, and magnesium excretion; and
change in alkaline phosphatase extracted from L3; change in femur B:MD, BMC, and
cortical area. Ovarian hormone status effects were seen in final body weight; Hb; lOF-I;
urinary DPD and hydroxyproline excretion; change in urinary DPD crosslinks and
hydroxyproline excretion; and femoral BMO as measured by DXA and L3 true density.
Diet x OHS interactions were seen in urinary calcium excretion; femoral area; and femoral










and iron deficiency seem to exert detrimental effects on bone metabolism.
Despite dietary effects prior to surgical treatment, in change from surgery to
necropsy and diet x OHS interaction at necropsy on the above listed hone metabolism
parameters, no dietary effects were noted for bone strength at necropsy. It has been
hypothesized that bone strength may not be affected by ovariectomy as the greater
appositional bone growth associated with ovariectomy partially compensates for
cancellous bone loss (26). Also, it is possible that the dietary effects may have become
overshadowed by the strong and well-known effects ofhormone deficiency on bone.
Another explanation may be that the necropsy timing was too long after surgery as rats
continue to gain bone mass throughout the life span whereas humans do not; partial
recovery from hormone-induced bone loss may have occurred in our rats. More elevated
indices of bone resorption at fewer weeks post-ovariectomy have been previously
descnOed (6, 34).
In this study, dietary iron concentration impacted bone metabolism. Adequate iron
intake may contribute, in part, to the prevention of osteoporosis, a chronic debilitating
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Table 5 Effect of Diet and Ovarian Hormone Status (OHS) on Femur Variables of Female SD Rats l ,2
Area Area Change Length Length Change BMD BMO Change BMC
2 2
g/cm2 g/cm2mm mm em cm grams
Diet and OUS
6 ppm Sham 1.75 + 0.03
3 0.18 + 0.033 ~.70 + 0.033 0.19 + 0.033 0.163 ±0.002 0.025 ±0.0043 ,- 9.24 + 0.21
6 ppm Ovx 1.85 + O.03b
U b b 0.160 + 0.002 0.008 + 0.0043 ,11 9.27 ± 0.200.28 + 0.03 3.80 + 0.03 0.29 + 0.03 - -
12 ppm Sham 1.78 ±0.033 •b 0.13 ±0.033 3.70 + 0.033 0.18 + 0.033 0.158 + 0.002 0.013 + 0.004b,- 8.96 ±0.21- -
12 ppm Ovx 1.81 ±0.033 ,b 0.17,± 0.033 3.72 + 0.033 0.20 + 0.033 0.157 + 0.002 0.00041 + O.OO4h ,# 9.13+0.21- -
35 ppm Sham 1.79 ±0.033 •b 0.16 ±0.033 3.68 + 0.033 0.17 + 0.033 0.163 ±0.002 0.012 ±0.004b.- 9.47 + 0.22
35 ppm Ovx 1.79 + O.03a•b 0.15 + 0.033 3.71 + 0.03
3 0.20 + 0.03a 0.159 ±0.002 (-0.0009) ±0.004b•1I 9.23 + 0.21- -
150 ppm Sham 1.66 ±0.03c (-0.03) ±0.03c 3.58 ±0.03c 0.01 + 0.03c 0.157 ±0.002 (-0.0064) ±0.004c,- 8.59 + 0.20
150 ppm Ovx 1.81 ±O.03a•b 0.12 ±0.033 3.74 ±0.033 ,b 0.17 ±0.033 0.159 ±0.002 (-0.0072) ±0.004c•1I 9.29 + 0.22-
P Value
Diet NS <0.0001 0.034 <0.0001 NS <0.0001 NS
OUS 0.0024 0.0024 0.0003 0.0003 NS 0.0006 NS
Diet x OUS 0.0822 0.0822 0.0633 0.0633 NS NS NS
1 Diet groups not sharing the same letter are significantly different. 2 OHS groups not sharing the same symbol are significantly different.
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Table 5 Effect of Diet and Ovarian Hormone Status (OHS) on Femur Variables of Female SD Rats l•2
BMC Change Cortical Area Cortical Area Change
2 2grams mm mm
1
0.08 ±0.01 a
0.07 + 0.01 a
b0.05 ±0.01
0.04 + 0.01 b
0.06 ±O.Olb




























I Diet groups not sharing the same letter are significantly different. 2 OHS groups not sharing the same symbol are significantly different.
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Table 6 Effect of Diet and Ovarian Hormone Status (OUS) on L3 Variables in Female SD Rats1,2
True Density True Density Change ALP ALP Change
"\
g/em3 uKat/g boneg/cm- uKat/g bone
Diet and OHS
•
0.064 + 0.0093,* 25.21 ±3.483 7.44 + 3.4836 ppm Sham 1.32 + 0.01
6 ppm Ovx 1.27 + 0.01# 0.020:±: 0.0083 ,# 23.20:±: 3.323 5.43 + 3.323
• 0.048 +- 0.0093 ,b,. 17.15 + 3.483,c (-5.57):±: 3.48h12 ppm Sham 1.32 + 0.01
12 ppm Ovx 1.28 + 0.01 # 0.006 :±: 0.0093 ,b,# 20.80 + 3.483 ,c (-1.92) :±: 3.48h
• 0.041 + O.OlOb,c" 19.65 + 3.673 ,c 5.86 + 3.67335 ppm Sham 1.33 + 0.01
35 ppm Ovx 1.28 + 0.01# (-0.016) :±: 0.009b,c.# 19.16 + 3.483 ,c 5.36 + 3.483
•
0.021 ±0.009c" 16.80 + 3.32b,c b150 ppm Sham 1.33 + 0.01 0.15 + 3.32
150 ppm Ovx 1.30 + 0.01 # (-0.010) ±O.OlOc,# 13.68 + 3.67b.c (-2.98) + 3.67b-
P Value
Diet NS 0.0009 0.0873 0.0082
OUS <0.0001 <0.0001 NS NS
Diet x OUS NS NS NS NS





Table 7 Effect of Diet and Ovarian Hormone Status (OHS) on Urinary Hydroxyproline (OH-Pr) and Oeoxypyridinoline (OPO)
Excretion
OH-Pr Surgery OH-Pr Necropsy OH-Pr Change OPO Surgery OPO Necropsy OPO Change
Oiet and OUS umol/umol cr umol/umol cr umollumol cr umollumol cr umollumol cr umollumol cr
0.74 + 0.081 a • • 8.2 ± 0.79a • •6 ppm sham 0.58 ± 0.094 (-0.16)±0.10 3.8 + 0.84 (-4.4) ± 0.80
0.68 + o.ona 0.82 ± 0.09011 II 9.2 + 0.75a # 1.2 + 0.80116 ppm ovx 0.14 + 0.09 10.4 + 0.80
0.51 + 0.081 b • • 7.0 + 0.79a.b • •12 ppm sham 0.39 + 0.094 (-0.13) ± 0.10 3.2 + 0.84 (-3.8) ± 0.80
12 ppm ovx 0.57 ± 0.081 h 0.73 + 0.094
11 0.16 + 0.10# 8.7 t- 0.79a,b # (-0.10) ± 0.80#8.6 + 0.84
0.47 ± 0.091 b
• (-0.041)± 1.10• 6.6 + O.83b • •35 ppm sham 0.43 + 0.099 3.5 ± 0.89 (-3.1) ± 0.85
35 ppm ovx 0.54 + 0.081 b 0.55 + 0.094# 0.013 + 0.10# b # #6.9 + 0.79 8.8 + 0.84 1.9 + 0.80
0.68 ± o.ona,b • (-0.22)±0.10
• b • •150 ppm sham 0.46 + 0.090 5.5 ± 0.75 2.4 + 0.80 (-3.1) ± 0.77
0.49 ± 0.08Sa,b 0.64 + 0.09911 /I b # (-0.048) ± 0.86#150 ppm ovx 0.16 ± 1.00 7.9 + 0.83 8.0 ± 0.89-
Pvalue
Oiet 0.0737 NS NS 0.0363 NS NS
OUS NA 0.0013 0.0006 NA 0.0001 <0.0001
Diet x OUS NA NS NS NA NS NS





Table 8 Effect of Diet and Ovarian Hormone Status (ODS) on Urinary Mineral Excretion in Female SO Rats!
Mg Surgery Mg Necropsy P Surgery P Necropsy Ca Surgery Ca Necropsy
Diet and OUS umollumollcr umol/umol/cr umollumollcrumol/umol/cr umollumollcr umol/umollcr
6 ppm sham 9.37 ±0.81 a 8.11 + 1.01 3.89 + 0.40 4.00 + 0.403 5.42 + 0.523 7.38 + 0.85 3
- -
6 ppm ovx 7.70 ±0.783 8.86 + 0.96 3.84 + 0.38 b 3.74 ±0.493 6.57 ±0.85a3.00 + 0.38
b 6.56+ 1.01 3.91 ±0.40 3.49 ±O.4Oa 2.18 --I 0.52b 3.83 + 0.85b,c12 ppm sham 6.14 ±0.81 - -
12 ppm ovx
b 6.13 + 1.01 4.57 + 0.40 3.19 + 0.40b 3.77 ±0.52b 5.89 ±0.85 a,c7.62 ±0.81
b 6.82 + 1.07 3.49 + 0.42 3.69 ±0.42a 2.75 ±0.58b 5.34 ±0.89a,c35 ppm sham 7.34 ±0.86
35 ppm ovx
b 6.00 + 1.01 4.10 + 0.40 b 2.18 + 0.52b 5.12 + 0.853 ,c5.98 ±0.81 2.85 + 0.40 - -
b 7.21 + 0.96 3.90 + 0.38 4.26 + 0.38a b b150 ppm sham 7.32 ±0.78 2.49 ±0.49 2.57 ±0.81
5.91 ±O.86b 7.60 + 1.07 3.30 + 0.42 b 2.01 + 0.54b 6.23 + 0.893150 ppm ovx 2.99 + 0.42-
Pvalue
Diet 0.0339 NS NS NS 0.0002 0.0197
OUS NA NS NA 0.0033 NA 0.057
Diet x OUS ~A NS NA NS NA 0.0401





Table 9 Effect of Diet and Ovarian Hormone Status on Hematological Status of Female SD Rats l ,2
RBC HB HeT MCV MCHC PLT RETIC
Diet and OHS l06/mm
3 g/dl % 3 g/dl lO3/mm3 lOG/mm3urn
6 ppm sham 7.80 ± 0.18
3 13,41 ± 0.243 ,- 33.44 ± 1,43 47.30 ± 1.31 3 36.79 ± 1.30 597.00 ± 60.97 0.33 ± 0.0253
6 ppm ovx 8.43 ± 0.193 14.11 ± 0.25
3
,# 38.73 ± 1.51 46.89 ± 1.38a 36.47 ± 1.38 531.00 ± 105.600.29 ± 0.0283
12 ppm sham 7.46±0.I8b 14.27 ± 0.24
b
,· 38.38±1,43 51.70±1.31 b 37.19±1.30 638.33±35.20 0.20±0.025b
12 ppm ovx 7.63±0.21 b 14.97±0.26
b
,# 40.01±1.60 52.38±1.46b 37.43±1.46 566.57±39.91 0.19±0.028b
35 ppm sham 7.38±0.19
b 14.40±0.25b,- 38.94±1.51 53.13±1.46b 37.04±1.46 541.33±43.11 0.23±0.030b
~5 ppm ovx 7.32 ± 0.2l b 14.60 ± 0.26
b
,# 38.56 ± 1.60 52.75 ± 1.46b 37.85 ± 1.46 587.86 ± 39.91 0.18 ± 0.028b
b b· b b
150 ppm sham 7.50 ± 0.18 14.17 ± 0.24' 38.58 ± 1.43 51.60 ± 1.31 33.41 ± 1.30 579.38 ± 37.34 0.20 ± 0.027
ISO ppm ovx 7.58±0.21
b 14.94±0.26b,# 40.19+1.60 53.13+1.46b 37.21 +1.46 571.75+37.34 0.21 +0.028b
Pvalue
Diet 0.0012 0.0022 NS 0.002 NS NS 0.0001
OHS NS 0.0013 NS NS NS NS NS
Diet x OHS NS NS NS NS NS NS NS






Figure 1 Effect of dietary iron and ovarian hormone status on final body















































Diet and Ovarian Hormone Status
I Treatment groups not sharing the same number are significantly (P<O.05) different.





Figure 2 Effect of dietary iron on serum insulin-like growth factor 1 (IGF-I)






























Figure 3 Effect of ovarian hormone status on serum insulin-like growth






















The purpose of this research was to further clarify the association between dietary
iron consumptio~ hormonal status, and bone metabolism. We attempted to detennine if
significant differences would exist in bloo~ urinary, and radiographic indicators ofbone
metabolism and in bone parameters based on surgical and dietary treatment.
HYPOTHESIS TESTING
The results of hypothesis testing are given below.
1) There will be no significant differences by diet or OHS group and no significant diet x
OHS interaction in final body weight. This was rejected for OHS as the ovx group was
significantly heavier than the sham group. This failed to be rejected for diet and diet x
OHS interaction as no significant differences were seen.
2) There will be no significant differences by diet or OHS group and no significant diet x
OHS interaction in bone metabolism as measured by:
a) insulin-like growth factor-I (IGF-I) at necropsy. This was rejected for diet and
OHS as the animals fed the 6 ppm diet and the ovx group exhibited higher serum levels
than other groups. This failed to be rejected for diet x OHS interaction as no significant
differences were seen.
b) alkaline phosphatase (ALP) extracted from bone at necropsy. This was rejected
for diet, OHS and diet x OHS interaction as no significant differences were seen.
However, this was rejected for change for diet as the animals fed the 6 ppm diet exhibited
greater change from surgery than did other groups. This failed to be rejected for change
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for OHS and diet x OHS interaction as no significant differences were seen.
c) urinary excretion ofcalcium (Ca) pre-surgery and at necropsy. This was
rejected pre-surgery as the animals fed the 6 ppm diet exhibited greater excretion than
other groups. At necropsy, this was rejected as a diet x OHS interaction was seen with 6
ppm sham and 6 ppm ovx exhibiting greater excretion than other groups.
d) urinary excretion ofmagnesium (Mg) pre-surgery and at necropsy. This was
rejected pre-surgery as the anima.1s fed the 6 ppm diet exhibited greater excretion than
other groups. At necropsy, this failed to be rejected for diet, OHS, and diet x OHS
interaction as no significant differences were seen.
e) urinary excretion of phosphorous (P) pre-surgery and at necropsy. This failed
to be rejected pre-surgery as no significant differences were seen. At necropsy, this was
rejected for OHS as the sham group exhibited higher excretion compared to the ovx
group. This failed to be rejected at necropsy for diet and diet x OHS interaction as no
significant differences were seen.
f) urinary excretion of free deoxypyridinoline (DPD) pre-surgery and at necropsy.
This was rejected pre-surgery as the animals fed the 6 ppm diet exhibited greater excretion
than other groups. At necropsy, this was rejected for OHS as the ovx group exhibited
greater excretion and greater change from surgery than the sham group. This failed to be
rejected at necropsy for diet and diet x OHS interaction as no significant differences were
seen.
g) urinary excretion ofhydroxyproline pre-surgery and at necropsy. This was
rejected pre-surgery as the animals fed the 6 ppm diet exlubited greater excretion than
-
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other groups. At necropsy, this was rejected for OHS as the ovx group exhibited greater
excretion and greater change from surgery than the sham group. This failed to be rejected
at necropsy for diet and diet x OHS interaction as no significant differences were seen.
3) There will be no significant differences by diet or OHS group and no significant diet x
OHS interaction in bone size at necropsy as measured by:
a) femur length. This was rejected for diet x DRS interaction as the animals fed
the 6 ppm ovx group exhibited greater length and greater change from surgery compared
to 6 and 150 ppm sham groups.
b) femur area This was rejected for diet x DRS interaction as the 6 ppm ovx
group exhibited greater area and greater change from surgery compared to 6 and 150 ppm
sham groups.
4) There will be no significant differences by diet or OHS group and no significant diet x
DRS interaction in bone density ofthe femur (DXA and Archimedes') or L3
(Archimedes') at necropsy as measured by:
a) dual energy x-ray absorptiometry (DXA). This was rejected for diet as the
animals fed the 6 ppm diet had greater change from surgery in femur HMD and cortical
area than animals fed other diets. This was rejected for OHS as the sham group exhibited
greater femoral density than the ovx group. This failed to be rejected for diet x DRS
interaction as no significant differences were seen.
b) Archimedes' principle. This was rejected for diet as the animals fed the 6 ppm
diet had greater change from surgery in L3 true density than animals fed the other diets.
This was rejected for DRS for L3 as the sham group exhibited greater density than the
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OVX group. This failed to be rejected for L-3 for diet x OHS interaction as no significant
differences were seen. This failed to be rejected for femur for diet, ORS, and diet x ORS
interaction as no significant differences were seen.
5) There will be no significant differences by diet or OHS group and no significant diet x
ORS interaction in bone mineral content at necropsy as measured by:
a) dual energy x-ray absorptiometry (DXA). This was rejected for diet as the
animals fed the 6 ppm diet had greater change from surgery in femoral BMD than animals
fed the other diets. This failed. to be rejected for ORS and diet x OHS interaction as no
significant differences were seen.
6) There will be no significant differences by diet or DRS group and no significant diet x
ORS interaction in bone strength at necropsy as measured by:
a) remur fracture force. This failed to be rejected for diet, OHS, and diet x OHS
interaction as no significant differences were seen.
SUMMARY AND CONCLUSIONS
Our findings indicate significantly different blood, urinary and DXA indicators of
bone metabolism based on both surgical and dietary treatment. Diet effects were seen in
Hb; IGF-I; pre-surgical urinary DPD, hydroxyproline, calcium, and magnesium excretion;
change in bone ALP; and change in femoral BMD, BMC, and cortical area. Ovarian
hormone status effects were seen in final. body weight; Hb; IGF-I; urinary DPD and
hydroxyproline excretion; change in urinary DPD and hydroxyproline excretion from
surgery; and femoral and L3 BMD. Diet and OHS interactions were seen in urinary




The low dietary iron regimen was adequate to produce iron deficiency in the
animals given the 6 ppm diet. These rats were iron deficient as demonstrated by
hematological indices whereas the other rats were not.
Despite pair feeding to the 150 ppm sham group after surgery, the ovariectomized
animals were significantly heavier than the sham animals at necropsy. Reports on load
bearing providing partial protection against ovarian hormone deficiency induced bone loss
in rats have been conflicting (Mosley et a1. 1997, Peng et al. 1994, Wronski et al 1987,
Westerlind et al. 1997, Roudebush et al 1993). In this study, no correlation between final
body weight and femur area and length was found. An association between dietary iron
intake and bone density has been previously established in Caucasian women (Angus et at.
1988) but not fully investigated. Ahhough our ovariectomized animals were heavier than
the sham animals, no protection from bone loss appears provided as femoral BMO was
significantly lower in the ovx versus sham group.
Increased bone metabolism is apparent in the ovariectomized rats compared to
sham rats. Elevated serum IGF-I in the ovx versus sham animals indicates increased bone
fonnation and corresponds with other research in rats and humans (Kalu et aL 1994,
Mueller et al. 1994, Boonen et aI. 1996). Elevated total urinary DPD crosslinks and OH-
Pr excretion along with greater change in excretion ofboth from surgery in
ovariectomized versus sham rats indicate increased bone resorption (Seibel et a1. 1992).
These findings are similar to other research findings in rats and humans (Sims et at 1996,
Goulding et al. 1996, Diamond et aL 1989, Conte et al. 1989). Although indicators of
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both formation and resorption were increased in ovariectomized animals, net bone loss is
apparent in the significantly decreased femoral BMD, decreased L3 true density, and the
smaller change in these animals in L3 true density from surgery compared to sham.
animals. A trend of lower femoral BMC and greater medullary area in the ovariectomized
versus sham rats also support greater bone resorption than bone formation.
While the effects ofovariectomy on rat bone are well-documented, the effect of
dietary iron intake on bone has not been extensively investigated (Angus et a1. 1988,
Malecki et al. 2000). Diet effect on bone metabolism was seen in the animals given the 6
ppm diet. Animals fed the 6 ppm diet exhibited increased bone formation with higher
serum IGF-I and bone ALP extracted from L3 compared to animals fed the other diets. In
addition, diet x OHS interaction was noted in femur area and length with 6 ppm ovx
animals having greater area, length and change in area and length from surgery compared
to other groups. The rats given the 6 ppm diet also had the greatest change in femur
BMD, femur BMC, femur cortical area, and L3 true density although there were no
significant differences in the mean values ofthese variables. The animals given the 6 ppm
diet also demonstrated increased bone resorption with increased urinary excretion of DPD
crosslinks, OH-Pr, Ca, and Mg pre-surgery compared to animals given the other diets.
Diet x OHS interaction occurred for urine Ca excretion at final urine collection with the 6
ppm sham and 6 ppm ovx groups excreting more than the other groups.
Although diet effects, OHS effects, and diet x OHS interactions occurred in the
above listed bone metabolism parameters, no effects were noted for bone strength at
necropsy. There are several possible explanations for this finding. The midshaft of the
- '""
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femur may not be the optimal site for testing femur fracture force. The midshaft contains
primarily cortical bone as opposed to the femoral neck which is predominantly composed
of trabecular bone. Trabecular bone is more affected by ovarian hormone deficiency than
is cortical bone. Also, human hip fractures most often occur in the femoral neck. Another
explanation may be that necropsy was performed too long after surgery. More elevated
indices ofbone resorption at fewer weeks post-ovariectomy have been previously
described (Wronski et aL 1987, Chan and Swaminathan 1998). Since rats continue to gain
bone mass throughout the life span, partial recovery from honnone-induced bone loss may
have occurred in our rats. As to lack ofdiet effect in strength testing, it is possible that
the strong effect ofovarian honnone deficiency overwhelmed diet effects seen earlier. It
is also possible that the rats fed the 6 ppm diet were recovering bone mass as evidenced by
the greater changes from surgery to necropsy in femur BMD, BMC and cortical area and
L3 true density. It has also been hypothesized that bone strength may not be affected by
ovariectomy as the greater appositional bone growth associated with ovariectomy partially
compensates for cancellous bone loss (Peng et a1. 1997).
Looking at the larger experiment including the skeletally mature and the ovarian
honnone altered rat phases, it appears that adequate dietary iron intake could represent an
important factor in proper bone metabolism, particularly during growth. In our study, iron
deficiency adversely affected bone during rapid growth, and the iron deficient animals
experienced accelerated bone growth after skeletal maturity. As such, optimal iron
nutrition, especially in growth, could possibly playa role in the prevention of the chronic
and debilitating osteoporosis, a disease high in human and economic cost.
SUGGESTIONS FOR FURTHER RESEARCH
In this study, dietary iron intake impacted bone metabolism; however, additional
research is necessary to further investigate this effect. Possibilities for further research
include a larger study with an increased number of necropsy dates, including necropsy
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